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 Willis, Sharese. Ph.D. The University of Memphis. May 2010. A Burkeian 
Analysis of the Embryo in the Congressional Debate over Federally Funding Embryonic 
Stem Cell Research (1998-2001). Major Professor: Loel Kim, Ph.D. 
Debates about publicly funded science research have attracted the interest of 
various types of stakeholders who use different strategies to argue their positions. The 
more scientists use human biological material as their focus of study, the more 
nonscientists call for and participate in debate about such research. In this dissertation, I 
study the debate about embryonic stem cell research by analyzing transcripts from 
Congressional hearings held from 1998 to 2001. In the study, I center my analysis on 
how supporters and opponents of the research variously defined the embryo and 
embryonic stem cells according to their own interests. To accomplish this, I use Kenneth 
Burke’s dramatistic pentad as a rubric to identify components of the embryo’s journey 
from its creation to the end proposed by the hearing witness, whether implantation in a 
womb or transplantation in a patient. Burke proposes that the pentad be used to identify 
what people are doing and why they are doing it. The study examines what people are 
doing with the embryo and why they are doing it. 
 In this dissertation, I aimed to answer the following questions: How is the embryo 
defined? And how does the embryo become a treatment for conditions beyond infertility? 
The results of the study indicate that hearing participants defined the embryo according to 
its context, its procedural origin, and its future direction. Also, supporters of the research 
portrayed the embryo as a treatment by surrounding the embryo and embryonic stem cells 
with people and settings that suggest research and then medical application. 
vi 
 The findings of the study suggest that definitions are malleable and can be used 
effectively as a tool of persuasion. In addition, members of the lay public who wish to 
participate in debates about publicly funded science should be aware of the definitional 
perspective of government entities and the resources that they have to construct their 
arguments. Finally, budding scientists also would benefit from training in argumentative 
strategies because contemporary public science requires that efforts be made outside of 
the laboratory in order to pursue the research of the laboratory itself.  
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Chapter 1:  Introduction  
Problem Statement 
In the United States, Congressional hearings are the most likely places for 
scientific controversies to be vetted at a public level, particularly for public policy in 
healthcare and medical research. These settings provide the main forum in which 
scientists and nonscientists argue their positions about how science should be conducted. 
In part, because these hearings play such an important role in determining which 
scientific trajectories are funded, this rhetorical sphere occupies an important place in the 
realm of scientific discourse. The outcomes of this discourse also bear directly on the 
economic vitality of the scientific community since scientists working in the public sector 
at university research labs receive the lion’s share of their funding from the U.S. 
government. Finally, the nation itself stands to be impacted by academic scientific 
research since the outcomes of such research are medical treatments and products that 
affect quality of life for individuals and wield potentially significant economic 
consequences for the public. In 2006, U.S. biotechnology1 revenue related to healthcare 
was $58.8 billion (Biotechnology Industry Organization, 2009). In other words, what 
happens in Congressional hearings in terms of science policy is no small matter. A recent 
case that bears this out is the debate over federal funding of embryonic stem cell research, 
research that much of the scientific community contends will lead to cures and treatments 
for many of mankind’s most daunting diseases. 
 
1 Biotechnology is the use of biological processes to solve problems or make 
useful products (Biotechnology Industry Organization). 
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Supporters of the research propose that embryos no longer needed for in vitro 
fertilization (IVF) procedures completed in the course of infertility treatment can and 
should provide suitable biological material for the laboratory. As biological material, the 
embryo can be used in a number of scientific experiments that may lead to therapies. 
Opponents, however, suggest that for embryos unused in infertility treatment, the 
laboratory is a final resting place for unfulfilled gestation to birth. In other words, 
embryos belong in wombs so that they can, in the end, become members of families. In 
witness testimony in Congressional hearings, the arguments refer to the embryo in 
basically two ways: in one, the embryo is an entity whose future is to attain full 
personhood, or at least to have the chance. The other camp argues that the embryo 
intended for use in infertility treatment can be a resource for other types of treatment 
through the disaggregation of the embryo’s cells. Although at this writing in 2009, 
federal funding is now allowed for embryonic stem cell research (Wilson, 2009), the 
Congressional hearings on science policy leading up to the approval of federal funding 
still offer a rich scenario of analysis as an example of a forum of discourse of emerging 
science and technology. 
Project Description 
In this study, I examine witness arguments, pro- and con-, during the 
Congressional hearing debates on embryonic stem cells from 1998 to 2001. My goal is to 
answer the following question: What rhetorical strategies are used to switch the identity 
of the embryo from an entity intended for use in infertility treatment to an entity intended 
for use in the treatment of other conditions?  
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Using Kenneth Burke’s (1969) dramatistic pentad, I map the progression of the 
embryo and its biological derivatives (embryo, pluripotent stem cells, embryonic stem 
cells, stem cells, child, tissue, organs) from the IVF clinic to the patient’s body, both the 
infertility patient and the patient whom embryonic stem cell research is proposed to help. 
The pentad calls for the identification of scene (location), act, agent (a person who acts), 
agency (the means or tool used to act), and purpose (the reason an act is performed). I 
create pentadic maps for each stakeholder type and then compare them in order to answer 
my research question. 
Study Rationale  
Arguing for new science and medicine. Basically, my question is a question of 
definition. Surely, the embryo may be defined in numerous ways beyond the definitions 
that I seek. Nonetheless, the definitions that are of concern in the present study provide 
part of the scaffolding for the expansion of science. That is, embryo science. The 
witnesses in the debate are trying to determine whether embryo science is synonymous 
with IVF technology and infertility treatment or whether embryo science is that and 
more—specifically, the development of newer technologies that will be used to treat 
additional medical conditions. Ultimately, with the proposed expansion of embryo 
science comes the expansion of its discourse. 
Discourse studies about embryo science. The expansion of embryo discourse has 
garnered some attention, but scholarship in this area is limited, especially in the U.S. 
Matthew Weed (2005) compares the ethical and political discourse about embryo 
research in the U.S. and Great Britain, but his examination of discourse is broad and does 
not evaluate the mechanisms that were at work in the discourse, just that discourse 
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differences existed. Most of the discourse studies about embryo research have been 
completed by British sociologists (Mulkay, 1993, 1997; Parry, 2003). For instance, 
Michael Mulkay (1997) has shown that in a debate in Great Britain about government 
policies for research using embryos, “rhetorics of hope” were used to express support for 
science while “rhetorics of fear” were used to convey that science is breeching “basic 
cultural categories and moral values” (p. 124). Mulkay (1997) shows how fear was 
stoked by such ideas as the “destruction of ‘unborn children’ in scientific laboratories” (p. 
187). Also a British sociologist, Sarah Parry (2003) suggests that part of the argument in 
the debate over embryonic stem cell research focuses on what to call a scientific 
technique used for different aims. For instance, scientists who wanted to use cloning to 
arrive at treatments for diseases distinguished between “therapeutic cloning” and 
“reproductive cloning” to allay fears that they would clone and implant embryos for live 
birth. Both Mulkay (1997) and Parry (2003) demonstrate the rhetoric of hope and fear as 
features of embryo science rhetoric. However, they implement “rhetoric” in their study in 
its broadest sense—as in Aristotle’s “means of persuasion”—and lack a fine rubric for 
rhetorical analysis. In this study, I demonstrate multiple facets of the recent argument 
about embryo science and apply a more complicated notion of rhetoric by using Burke’s 
pentad to enable a deeper discussion about the characteristics and interrelationships of the 
components of the stem cell argument.  
The Methodology 
In A Grammar of Motives, Kenneth Burke (1969) proposes dramatism as a 
method for identifying how people use language to say what they are doing and why. He 
draws from the terminology of the theater to place the analysis of language within a 
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“live” narrative context so that the rhetorical components can be identified, their 
relationships to each other defined, and, thus, the rhetorical forces better seen and 
understood. Burke’s dramatism is suited to the present study because it is used to identify 
sources of ambiguity, for, according to Burke, ambiguity is necessary for transformation 
to occur. He notes that no two things are exactly alike; therefore, if the same term is used 
to describe both, the definitions for both things are ambiguous. This lack of clarity calls 
attention to the need for transformation so that more precise definitions can be achieved. 
In the case of infertility treatment and in the case of the proposed treatment for other 
disorders, the starting material is the embryo and this term is used differently by the 
stakeholders. The corpus in this study exhibits ambiguity in the definition of the embryo 
and how it should be used.  
In A Grammar of Motives, Burke (1969) proposes that his grammar is but a 
method to name the components of linguistic action while symbolic analysis explicates 
the meaning of artistic symbols and rhetorical analysis shows the persuasive elements of 
the action. According to Burke, his grammar of motives is applicable to theological, 
metaphysical, and juridical issues. Conversely, Burke claims that art calls for symbolic 
analysis, and, among other topics, “parliamentary” and “social sparring” issues are 
applicable to rhetoric (p. xviii). However, he adds that his grammar, symbolic analysis, 
and rhetoric sometime overlap. The present study is such an example of overlap, as it 
addresses social sparring over the theological, metaphysical, and parliamentary concerns 
over embryonic stem cell research.  
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Background 
In November 1998, scientists, for the first time, isolated human embryonic stem 
cells using funding from a private source. Subsequently, President Clinton called for his 
bioethics advisory board, the National Bioethics Advisory Council (NBAC), to consider 
the ethical implications of this research since embryos or cells from embryos (a 
distinction that would be made by some hearing witnesses) would be used as material for 
scientific study. Shortly thereafter, the Senate called for hearings on the research. In the 
hearings, scientists and scientific citizens2 engaged in a dialogue spanning eight years of 
reports (1998-2006), expert opinion, and more than 17 Congressional hearings. In 
preparation for these 17 hearings, witnesses often wrote statements in advance of their 
testimony. In the official transcripts, these documents are called prepared statements. In 
these prepared statements, supporters of embryonic stem cell research would contend that 
embryos were the ideal source of stem cells, and not umbilical cord blood or adult 
sources, to help scientists in their quest to find treatments and cures for some of the most 
destructive medical conditions. Conversely, opponents of the research would argue that 
embryos were not material to be used for scientific study and that the aims of the research 
would be best achieved by pursuing cord blood and adult stem cells as research material. 
Participants in the hearings argued that the decision of the legislators to either fund the 
research or not would set the course for science, at least a certain type of science, for the 
U.S.  
 
2 Scientific citizen” is a term used by Alan Irwin to describe nonscientists who are 
involved in the making of science policy. 2001 
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The current debate belongs in the family tree of concerns about how human body 
parts (i.e., cells, tissue, fluids, etc.) should be used. The legacy of Henrietta Lacks is an 
illustrative case of the origins of the debate. Lacks died of cervical cancer in 1951. 
During her medical treatment, cells were procured that led to the ability of researchers to 
grow cells outside of the body (Skloot, 2000). These cells, known as HeLa cells, have 
been used in laboratories all over the world. Lacks’s family was unaware of the travels 
and uses of the cells until 1975. The technology to grow human cells in culture is a 
salient feature of embryonic stem cell research, but the kinship with the HeLa cells 
doesn’t end there. Although procedures for informed consent have developed 
considerably since the 1950s, the question still remains about what is the proper use of 
body parts. In the case of the embryo, the question may even be more significant—what 
should be done with a cell that can give rise to an entire body? Furthermore, what is the 
federal government’s role regarding the scientific uses of this cell? 
The federal process for funding biological science. The making of science in the 
U.S., especially academic scientific research, calls for funding from a variety of sources 
with the federal government being the largest underwriter of academic scientific research. 
Thus, scientists are increasingly involved in politics (Davis, 2000). The federal 
government funds 59% of research and development at colleges and universities 
(American Association for the Advancement of Science [AAAS], 2006). In 2005, the 
National Institutes of Health3 (NIH) received more than $28 billion, just a part of the 
federal government’s total budget for the sciences (AAAS, 2006). The natural course of 
NIH funding is that the Congress approves funding for the agency, and NIH (2009) funds 
 
3 The NIH, in turn, distributes funds to research institutions through grants. 
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the work of researchers whose projects they deem worthy, either through a process that 
announces NIH priorities or through one in which investigators initiate the parameters of 
the research. In 2001, President George W. Bush made an announcement that put even 
further limitations on what could be funded with NIH dollars. 
Policy. On August 9, 2001, President George W. Bush issued a Presidential 
Announcement that federal funding would be allowed for research that used the 60 stem 
cell lines that existed as of the date of his announcement. This announcement was 
consistent with a President’s constitutional right to set policy through a presidential 
directive (Relyea, 2007). On July 19, 2006, President George W. Bush vetoed a bill that 
would have expanded federal funding capability to apply to embryonic stem cell lines 
established after August 9, 2001 (Klein, 2006). President Bush also vetoed a second bill 
that would have allowed federal funding for embryonic stem cell research. On March 9, 
2009, Bush’s 2001 policy was reversed by President Barack H. Obama. 
Politics: a complex process. In this study, I make no claims about who was most 
persuasive. Such claims cannot be supported in the mélange that is U.S. politics with its 
lobbying organizations, political allegiances, economic pressures, and so on. However, 
the results of this study suggest that U.S. citizens become more critical of political 
processes and more aware of the evolution of rhetorical constructs in public discussions, 
in particular Congressional hearings. 
Congressional hearings. The Congressional hearings on stem cell research 
funding are part of a tradition of the Congress in which legislators seek information, aim 
to inform the public, or obtain focus on a particular issue (Sachs, 2004). Another purpose 
of these hearings is to provide an arena for citizen input. When deciding to hold a 
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hearing, a committee might consider several factors, “including the salience of issues to 
the nation, the importance of policies to interest groups, and matters of significance to the 
President, Senate leaders, committee leaders, and particular members” (Sachs, 2004, p. 
6). In the hearing approval process, committee staff members often prepare a memo that 
provides an overview of the proposed hearing, including names of possible witnesses. 
Once a hearing has been approved, chairpersons may invite witnesses who will give a 
broad spectrum of perspectives on the issue at hand, or the witnesses may advocate 
certain views. Those who are invited to testify may be asked to provide biographical 
information and a copy of their written testimony in advance. Such prepared statements 
comprise the corpus of this study. 
Congressional hearings on human embryonic stem cell research. From 1998 to 
2006, the Senate and the House of Representatives held several hearings to discuss the 
status of human embryonic stem cell research and whether such research should be 
funded with tax payer dollars. In 1998, the almost simultaneous isolation of human 
embryonic stem cells by John Thomson and embryo-like stem cells (from fetal origin) by 
John Gearhart sparked a debate about what is scientifically and medically possible with 
these cells, which Thomson and Gearhart described as pluripotent (Wade, 1998). 
Until 1995, any research that used embryos was not eligible for federal funding 
because of a de facto moratorium. In 1978, the Ethics Advisory Board, which had been 
appointed by the Secretary of Health, Education, and Welfare, issued a report in which it 
concluded that research on early embryos was allowable if the sperm and egg were 
donated by a married couple (Ryan, 2000/2003). However, embryo research was never 
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funded by Congress, and neither Presidents Ronald Reagan nor George H.W. Bush was 
in favor of embryo research.  
In 1995, Representatives Jay Dickey and Roger Wicker successfully sponsored an 
amendment to the NIH appropriations bill for the year which would prohibit “research in 
which a human embryo or embryos are destroyed, discarded, or knowingly subjected to 
risk of injury or death” (Balanced Budget Downpayment Act, 1996). The amendment has 
been attached to the NIH appropriations bill ever since. Over the years, the scientific 
community has lobbied Congress to remove this ban. Finally, in the 1998 isolation of 
human pluripotent cells, many scientists and their supporters saw the prime impetus for 
removing the ban since the potential for tangible therapeutic results appeared to be great.  
Congressional hearings called on the subject gave scientific citizens the 
opportunity to affect the making of science. If funding of embryonic stem cell research 
were approved, a myriad of possibilities could be opened to supporters of the research. 
Pharmaceutical companies might be able to conduct testing on human tissues, a process 
considerably limited today by the shortage of available volunteers for clinical trials and 
concerns and regulations related to using humans to test unproven drugs. With the 
availability of funding for embryonic stem cell research, patients might also be able to 
receive life-saving organ transplants without having to depend on the precarious organ 
transplant system currently in place that depends on the availability of willing donors and 
suitable matches that diminish the possibility of the body’s rejection of tissue.  
Outline of Chapters 
Introduction. The introduction describes the discourse problem to be analyzed in 
the study. The chapter gives a background of federal policy related to embryonic stem 
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cell research and the general role of Congressional hearings in policy making. The 
chapter also identifies the general corpus of the federal debate over funding of embryonic 
stem cell research. 
Literature review. This chapter provides the theoretical grounding for the study. 
The chapter reviews the literature on technical communication as it relates to public 
policy and the rhetoric of science. Kenneth Burke’s pentadic model is also explained, 
along with its relevance to the examination of science.  
Methodology. The chapter details text selection strategies and the coding scheme 
used in the study. Traditional pentadic analysis, multipentadic analysis, and grounded 
theory techniques are detailed. 
Results. In this chapter, I compare pentadic maps between types of witnesses, 
outlining the drama as portrayed by the hearing participants. The comparison shows the 
type of rhetorical strategies that the participants used in the debates to define the embryo 
as a treatment for infertility and/or as a treatment for other conditions. 
Discussion. In this chapter, I discuss the rhetorical choices identified in the 
analysis. Furthermore, I explicate the data according to Burke’s (1969) methods of 
definition. 
Conclusions. In addition, this chapter reflects on the aims of the study and 
ramifications of the findings for those who publicly debate federally funded science. This 
chapter also suggests areas for further study. 
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Chapter 2:  Literature Review 
The following review of literature stems from a premise that nonscientists and 
scientists together construct science. The text below includes a section on the social 
construction of science and describes the historical milieu to which the subject belongs. 
Also, because the topic of the study is about debating a type of science, a relevant review 
of the rhetoric of science is included to designate where the current study fits and where 
room has been made for it by omissions in past work. Finally, to assist me in finding the 
operative mechanisms at work in the rhetoric of the corpus, I detail Kenneth Burke’s 
dramatistic pentad.  
Social Construction of Science – Scientists and Nonscientists 
Scholars who claim that the making of knowledge, including scientific 
knowledge, is socially contingent usually focus on how experts construct knowledge 
within their own communities (Kuhn, 1970; Latour & Woolgar, 1979; Myers, 1990; 
Taylor, 1996). Of course, nonscientists are not working in the laboratory, but the making 
of modern science involves much more than laboratory activities. This study focuses on 
the ways in which scientists and nonscientists interact, argue, and potentially influence 
each other in a specific public context—U.S. Congressional hearings—as they engage in 
policymaking that directly affects scientific research (Taylor, 1996; Toumey, 1996, 
2006). According to cultural anthropologist Chris Toumey (1996), discussions of science 
in public contexts include scientists and nonscientists who engage in the scientific arena 
in a way in which one type of expertise is no more highly regarded than another, even 
scientific expertise. From this point of view, a concern about the societal results of 
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scientific activity is just as important as the expertise to carry out the scientific activity 
itself.  
Increasingly, when science shares a valence with deeply held values, members of 
the public become involved in the making of related policies (Leshner, 2005). Procedural 
practices in this direction began in the 1970’s. Scientists recognized that what they did 
inside the laboratory would need to be guided by discussions that occurred outside the 
laboratory. In this vein, the attendees of the Gordon Conference on Nucleic Acids of 
1973 published a letter in Science that expressed concerns about the negative potential of 
recombinant DNA technology, technology that made possible the splicing of DNA across 
species (Singer & Söll, 1973). The letter also announced the formation of a committee 
that would assess risks and recommend guidelines for research that used the new 
technology. However, the letter did not call for public involvement and actually was 
written in dense technical language meant for a community of scientists (Weiner, 2001). 
In 1974, a committee of the National Academy of Life Sciences published another letter 
in Science that called for a moratorium on the use of recombinant DNA techniques until 
more was known about the hazards of the technology (Berg et al., 1974). Unlike the 1973 
letter, the 1974 letter was announced at a press conference in order to allay any fears that 
might arise in the public domain. The letter also recommended an international scientific 
meeting at which recombinant DNA could be further explored. The resulting meeting 
was the 1975 Asilomar Conference. Although, through the media, the public was 
informed of the issue under consideration and the outcomes of the meeting, the public 
was not involved in any decision making regarding research guidelines; furthermore, the 
goals of the meeting were to find technical solutions, not social ones (Weiner, 2001).  
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In 1976, nonscientists began to insert themselves into conversations about the 
safety of conducting research using recombinant DNA techniques. The City Council of 
Cambridge, Massachusetts, was among the first citizens’ groups to ask scientists to 
explain the research and its safety ramifications for the community. This initial inquiry 
evolved into the Cambridge Experimentation Review Board (discussed below in the 
context of rhetoric). The U.S. Congress also introduced legislation to regulate safety 
surrounding the research (Weiner, 2001).  
Since the recombinant DNA discussions, there has been what Chris Toumey 
(1996) calls the “democratization of science.” Nonscientists have joined deliberations 
about science in a way that some scientists view as helpful to the future of the field. Alan 
Leshner (2005), chief executive officer of the American Association for the 
Advancement of Science, adopts the view that the traditional role of science as an 
expected change agent in society is being altered in the sense that increasingly, society 
wants to be involved in changes in science or to assist in guiding its direction. Contrary to 
many scientists of the early recombinant DNA era, Leshner and many of his colleagues 
are calling for an “inclusive approach” and a “common ground” with nonscientists in 
determining the course of science (p. 815). Even if some scientists still do not welcome 
the input of nonscientists, contributions of nonscientists have come to be expected in 
federally funded science. President Bill Clinton’s NBAC and President George Bush’s 
Council on Bioethics are just two examples that demonstrate the federal government’s 
expectation that scientists and nonscientists together will help to shape views on the best 
course that science should take.  
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Discourse of Public Debates about Science  
As I have already alluded, technical discourse is shared between specialists and 
nonspecialists in public discussions (Dombrowski, 1994). This is evidenced in several 
studies about the discourse of public debates in which science is used to inform policy 
decisions (Coppola & Karis, 2000; Killingsworth & Palmer, 1992; Shackley & Wynne, 
1996; Zehr, 1996). Still, how such discourse is involved in determining the course of 
science is a subject of current scholarly evolution. Craig Waddell’s essay on the 
recombinant DNA debate is one of the first rhetorical analyses of deliberations involving 
the lay public and science policy. Waddell’s study of the Cambridge Experimentation 
Review Board analyzes how the review board decided whether to allow experiments with 
recombinant DNA. According to Waddell, the review board was influenced by the pathos 
in the testimony of the witnesses and ultimately approved the research.  
Although advances in science have increased interaction between scientists and 
nonscientists, the interactions have been of little focus in technical communication. Even 
those technical communication studies that examine political discourse related to science 
do so mostly in the arena of science for policy, with environmental deliberative rhetoric 
being the exemplar of this domain. Nonetheless, a wide breadth of opportunities exists in 
scientific rhetorical research that has yet to be explored. 
Rhetoric of Science 
The current analysis furthers the study of how science is made from a discourse 
perspective. Early studies in the rhetoric of science centered on the scientific research 
article because the research article represented the conversations that circulated 
throughout the scientific community and moved science forward (Bazerman, 1988; 
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Ceccarelli, 2001; Fahnestock, 1986; Gilbert & Mulkay, 1984; Gross, 1988, 1990; 
Halloran, 1984; Harris, 1991, 1997; Moore, 2000; Overington, 1977; Pera & Shea, 1991; 
Prelli, 1989; Selzer, 1993; Taylor, 1994, 1996; Thompson, 1993; Wander, 1976; Yearley, 
1981; Zappen, 1989). For instance, Charles Bazerman (1988) observed how the scientific 
article has evolved over more than 300 years. S. Michael Halloran’s essay (1984) on 
James Watson’s and Francis Crick’s first paper on the DNA molecule showed how 
Watson and Crick developed a subtle ethos that was necessary to introduce a new 
understanding of the DNA molecule. Another example is Alan G. Gross’s (1988) 
comparison of Sir Isaac Newton’s arguments for his optical theory. Gross postulated that 
Newton offered the same theory in both of his arguments but that the latter argument 
included considerably more attention to the needs of his audience instead of a singular 
focus on the dynamism of his theory. In these analyses, rhetoric scholars demonstrated 
that the language used in the initial writings exceeded positivistic notions of science and 
that the authors had crafted their arguments to persuade their audiences.  
When Philip Wander (1976) initiated the term “rhetoric of science,” he included 
under its auspices persuasion relevant to public debate. The current study fits soundly 
within the rhetoric of science and helps to occupy a branch of study that is in need of 
growth in order to obtain the most accurate view of scientific discourse. The texts 
regarding scientific subjects created for contexts other than peer-reviewed journals—
including Congressional hearings, press conferences, and grant application processes—
open the purview of scientific discourse and have been called “scientific rhetorics” 
(Taylor, 1996, p. 97). Whereas articles targeted for peer-reviewed publication are 
essential in the process of building scientific knowledge, successful grant applications 
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and other explications of arguments championing scientific work also fall within the set 
of essential communication skills in the professional development of scientists (Merton, 
1973). Clearly, without the funding that is the scientist’s pragmatic outcome from 
successful findings and their publication, entire areas of scientific study and thought 
might be thwarted and thus, further science not conducted, further scientific articles not 
written, and the body of scientific knowledge potentially shaped in significantly different 
ways.  
This matter of funding is a central issue in human embryo research, the focus of 
this study. In fact, the connection between funding and human embryo research has 
introduced its rhetoric to the setting of the Congressional committee hearing. Although 
the rhetoric of this particular site has not been closely examined in the scholarly 
literature, some scholars have tended to the rhetoric of human embryo research in other 
places. 
Human Embryo Research in Great Britain 
In the U.S., much discourse has surrounded human embryo research since 1998, 
when scientists first isolated embryonic stem cells. However, human embryo research has 
a much longer history of discourse in Great Britain. In 1984, Dame Mary Warnock was 
asked by Parliament to lead a committee that would study issues surrounding embryo 
research and that would make relevant policy recommendations. The result was the 
Human Fertilisation and Embryology Authority (HFEA), established in 1990 to regulate 
research and clinical practice involving embryos (Wade, 2001). The responsibilities of 
the Authority are to license and monitor clinics that perform IVF and donor insemination; 
to regulate egg, sperm, and embryo storage; to provide information about clinic services; 
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to maintain a treatment register for the benefit of those born as a result of available 
services; to license embryo research; and to advise government on assisted reproductive 
technology (HFEA, 2006). The HFEA has a level of independence similar to the Food 
and Drug Administration in the U.S. in that it is not supposed to make decisions based on 
the prevalent political winds of the day (Weed, 2004). The U.S. has no such organization 
for the regulation of IVF and embryo research.  
Since 2001, scientists in Great Britain have been able to clone embryos for 
research that has therapeutic goals, distinguishing this type of research from reproductive 
cloning that might result in the birth of a human. Prior to 2001, five types of embryonic 
research were allowed in Great Britain, and they all entailed goals that would assist in 
problems of infertility. In 2001, an amendment to the 1990 Human Fertilization and 
Embryology Act expanded allowable therapeutic goals of embryonic research beyond 
infertility.  
Considering the development of British legislation on embryonic stem cell 
research, supporters of similar research in the U.S. had to bridge a larger rhetorical gap in 
making the case without pre-existing, accepted distinctions between research on the 
embryo and research on the stem cell. I argue that the rhetorical gap is bridged by 
presenting preferred dramas that involve the embryo. In this study, I use Kenneth Burke’s 
dramatistic pentad to show how the embryo is presented as the debate unfolds.  
The Pentad  
In A Grammar of Motives, Kenneth Burke (1969) presents the dramatistic pentad 
as a method for examining communicative acts to explain “what is involved when we say 
what people are doing and why they are doing it” (p. xv). The terms of the pentad mirror 
the dramatic stage. Like stage drama, Burke’s dramatistic pentad “treats language and 
thought primarily as modes of action” (p. xxii). The pentad encompasses five 
components. The act is “what took place, in thought or deed.” The act is central to each 
pentadic element. For instance, the scene may be located by first locating the act. Burke 
(1969) comments, “The nature of the scene may be conveyed primarily by suggestions 
built into the lines of the verbal action itself” (p. 3). Burke also clarifies the connection 
between scene and act in the question, “What kind of scene did he say it was, that called 
for such an act?” The scene is “the background of the act, the situation in which it 
occurred.” The agent is the “person or kind of person” who “performed the act.” The 
agency constitutes the “means or instruments” used, and the purpose is the generative 
impetus (Burke, 1969, p. xv). See Figure 1 for a model of the pentad as I understand it 
and as it is implemented in the present study: 
                        
 
Figure 1. Model of Pentad. 
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I chose Burke’s pentad as my methodology because of its flexibility. It did not 
come with the assumptions of some other rubrics that I had considered. For instance, 
recognizing that the corpus was an example of deliberative rhetoric, I considered using 
Cicero’s approach to deliberative rhetoric. However, I wondered whether his focus on 
“expediency” and “honor” in the deliberative rhetoric of Ancient Rome were germane to 
contemporary deliberative rhetoric. To address a more contemporary setting, I then 
considered discourse analysis to identify the presence of legitimation efforts. Van 
Leeuwen and Wodak (1999) define legitimation as “the question of why social practices 
or parts thereof must be the way they are” (p. 98). For the purposes of this study, the 
question would be, “Why must embryos be the material of therapeutic applications?” 
According to van Leeuwen and Wodak (1999), a social practice has a set of well-defined 
activities, participants that play certain roles, performance indicators (such as the 
objectivity associated with scientific work), a time for the activity, a place, tools and 
materials, dress and grooming, and eligibility conditions. Although legitimation analysis 
might be more appropriate for today’s setting than Cicero’s version of deliberative 
rhetoric, it still presumes legitimation of a particular social practice—in this case, the 
social practice of the embryo becoming a therapeutic application. I was still left with the 
need to find an analysis tool that would map the components of the corpus without the 
imbedded cultural assumptions of traditional rhetoric and discourse analysis. I found the 
solution in Burke’s dramatic pentad. 
Burke’s (1969) grammar provides a method to map the basic structure of an 
argument. He explains: “Strictly speaking, we mean by a Grammar of motives a concern 
with the terms alone, without reference to the ways in which their potentialities have been 
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or can be utilized in actual statements about motives” (p. xvi). So the grammar provides a 
beginning, but Burke also allows for analysis of the findings. He continues: “Speaking 
broadly we could designate as ‘philosophies’ any statements in which these grammatical 
resources are specifically utilized” (p. xvi). The methodology that I followed in the study 
began with the identification of pentadic elements without any assumptions of what I 
would find. After having a general map of the pentadic elements across witness types and 
positions, I applied Burke’s “Ways of Placement” documented in A Grammar of Motives 
to explain how various relations between the pentadic terms yield different insights. 
Burke’s ways of placement include ratios, definition, and the scope of a drama. 
Ratios. The elements of the pentad do not operate in isolation; they work together 
in pairs that Burke calls ratios, thus focusing on forces between components of a 
communicative act. The ratios show the symbiotic relationship between pentadic terms. 
In other words, together, a pair of pentadic terms make meaning that is different from the 
message conveyed by one pentadic term. For instance, Burke describes the scene as the 
container for the other pentadic terms. Burke (1969) clarifies the connection between 
scene and act in the question, “What kind of scene did he say it was, that called for such 
an act?” (p. 12). In terms of Burke’s ratios, the answer would be the scene-act ratio. 
Burke (1978) gives the following example of ratios: 
. . . in a time of great crisis, such as a shipwreck, the conduct of all persons 
involved in that crisis could be expected to manifest in some way the motivating 
influence of the crisis. Yet, within such a scene-act ratio, there would be a range 
of agent-act ratios, insofar as one man was ‘proved’ to be cowardly, another bold, 
another resourceful, and so on. (pp. 330-335) 
 
To take the analysis a step further, one might say that within the context of the 
shipwreck, one passenger is defined as resourceful and the other as cowardly. In another 
context, the same passengers might exhibit different responses. This analysis goes to the 
point of definition, another dimension of Burke’s ways of placing human motive. 
Definition. Burke (1969) describes three types of definition: familial, contextual, 
and directional. Burke’s familial definition describes according to a subject’s ancestry. 
Burke says of this type of definition, “In its purity, this concept stresses common ancestry 
in the strictly biological sense, as literal descent from maternal or paternal sources” (p. 
29). Furthermore, Burke says that familial definition is often “interwoven” with 
contextual definition (p. 26). According to Burke, when a definition is established in 
terms of something exterior to the entity being defined, the entity is said to be 
contextually defined. Burke describes it thusly, “To tell what a thing is, you place it in 
terms of something else” (p. 24). He elaborates on the role of contextual definition: “This 
idea of locating, or placing, is implicit in our very word for definition itself: to define, or 
determine a thing, is to mark its boundaries, hence to use terms that possess, implicitly at 
least, contextual reference” (Burke, 1969, p. 24). Contextual definition addresses the 
issue of where something should be placed and the boundaries of that placement. Finally, 
directional definition asks the question, “Where are you going?” (Burke, 1969, p. 31). 
The relevant question in this study is, “Where is the embryo going?” The corpus shows 
evidence of all three of the aforementioned types of definition, indicating that definition 
is at least one argumentative strategy used in the debate. Actually, the definition of the 
embryo potentially has been at issue since the creation of IVF techniques. 
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In 1978, Patrick Steptoe and Robert Edwards’s implementation of IVF techniques 
to create embryos changed the context of the embryo. The viable human embryo now had 
two potential contexts, in utero or in vitro. The ability to fertilize an embryo outside the 
womb by IVF marked what Edward Schiappa (2006) calls a definitional rupture. He says 
that definitional ruptures are disputes that occur when people cease to agree on old 
definitions, in this case, that human embryos are the earliest forms of human life and are 
created in a woman’s uterus where they develop. Schiappa adds that innovations made in 
the late twentieth century made traditional medical definitions particularly problematic. 
The in utero embryo can be defined in familial, contextual, and directional ways. It is 
a merger of the parents’ sperm and egg (familial). It is in the uterus or womb (context). It 
continues to grow until it develops into a fetus and is born—barring some negative 
incident—some months later (directional). No dictionary definition is necessary for the 
nonscientist’s use of embryo. I conjecture that most people have learned to use it as a 
referent to the early form of human life, and they expect this early form to be in a 
woman’s uterus. This use was most certainly the case before the advent of IVF. 
Schiappa’s (2006) view on how words are used are appropriate here: “ . . . most words 
are not acquired by reference to a dictionary but rather by reference to a prototypical 
exemplar. We learn to use words in later contexts based on the perceived similarities and 
differences to earlier uses” (p. 56).  
The ex utero embryo cannot be so predictably defined as the in utero embryo. While 
it is true that there is no getting around the familial definition of the merger between the 
parents’ sperm and egg, other rhetorical adjustments can be made to determine the non-
biological ancestry of the embryo and the embryonic stem cell. As for the context of the 
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womb, the ex utero embryo is more portable than its in utero alternative. As the data in 
this study show, a womb may be the ultimate context for an ex utero embryo, but so may 
a Petri dish in a research lab. Regarding directional definition, the ex utero embryo gives 
off no signals, biological or otherwise, of where it is going, so exterior forces (the 
witnesses in the case of the current discussion) determine where it goes and how. The 
how is composed of the rhetorical techniques that are identified in this study. 
The issue of contextual definition, especially, elicits questions of how broad or 
narrow the context is that defines the embryo. This concern is taken up in the next 
section. 
Scope and reduction. Burke borrows the term circumference from philosopher 
and psychologist William James to refer to the flexible boundaries of a scene. They can 
constrict to present a certain perspective or expand to present another. Burke (1969) 
explains: 
The word reminds us that, when ‘defining by location,’ one may place the object 
of one’s definition in contexts of varying scope. And our remarks on the scene-act 
ratio, for instance, suggest that the choice of circumference for the scene in terms 
of which a given act is to be located will have a corresponding effect upon the 
interpretation of the act itself. (p. 77) 
 
In terms of drama, one may imagine an entire stage full of actors or one actor illuminated 
by a spotlight. In this example, the circumferences are vastly different. A view of the 
entire stage might show multiple actions that involve multiple agents, whereas the 
spotlight might show the actions of a lone actor.  
 The circumference is one of the main indicators of the flexibility of Burke’s 
pentad as a tool of analysis. It allows the researcher to determine how broad or narrow 
the scope of analysis should be. For instance, in order to answer my research question, I 
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have determined the scope of my analysis to be the immediate realm of the embryo. In 
analyzing only the acts (and related pentadic elements) that impact the embryo, I am 
constructing a somewhat narrow circumference for methodological purposes. However, 
the ultimate analysis of the findings may show that this circumference has broader reach. 
Science, medicine, and the pentad. According to Burke (1969), dramas may have 
various circumferences. His concept of the technological circumference is applicable to 
the present study. Like other circumferences, the technological circumference is 
accompanied by “terminological reductions” (Burke, 1969, p. 117). In other words, 
particular terms are used to establish particular frames of reference. For example, Burke 
considers the role of science in the modern world, saying in one instance, “ . . . modern 
science is par excellence an accumulation of new agencies (means, instruments, 
methods)” (p. 275). These new agencies are expressed with linguistic innovations as well. 
In another instance, Burke comments on the relationship between technological and 
linguistic advances: 
Remember always that no modern instrument could have been invented, or could 
be produced, without the use of a vast linguistic complexity. A traffic signal 
seems very simple, but its production, distribution, and operation require a set of 
interlocking linguistic acts that would require a century to trace in their 
particularity. (p. 319) 
 
He also says that the nature of the laboratory is such that the purpose may be so 
aligned with agency that it is actually imbedded in the agency itself. Burke (1969) 
comments: “An instrument like a thermometer has its purpose so thoroughly built into its 
very nature, that it can do its work without purpose, merely by continuing to be itself” (p. 
281). In this study, the new agencies of science are embryonic stem cells. However, these 
new laboratory agencies do not come with their purpose already imbedded as does a 
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thermometer. Not only do the new agencies come without imbedded purpose, because 
they are untethered to the in utero scene, the in vitro embryo can be grammatically 
assigned in a way that allows rhetorical flexibility. For instance, because of legislative 
prohibitions, the in utero embryo could not have the purpose of developing medications 
for the treatment of cancer. Yet, this purpose is available for application—at least it is 
available for debate—in the case of the in vitro embryo. In disturbing the relationship 
between scientific means and purpose (What kind of tool is the in vitro embryo, and for 
what purpose is it to be used?), the in vitro embryo and the argument over its use make 
the pentad a fitting framework for this study. Other scholars have used the pentad to 
examine the dramatistic components of scientific research and medical practice. 
Martha Solomon’s (1985) pentadic analysis of scientific reports about the 
Tuskegee Syphilis Project1 is concerned with both scientific research and the practice of 
medicine. In the study, Solomon documents the centrality of agency in scientific 
reporting, but she also emphasizes the scene. According to Solomon, participants in the 
study were portrayed as agencies so that researchers could observe the effects of 
untreated syphilis. Solomon postulated that the depiction of the patients as agencies and 
scenes indicated that the researchers dissociated themselves from the humanity of the 
patients. 
Again, the quality of patient care is at issue in the dissertation of Cyd Charise 
Ropp (2001). Ropp juxtaposes the scientific model of obstetrics against the “nature” 
model of midwifery. In the dissertation, two pentadic maps—one for obstetrics and one 
for midwifery—are compared to show how the two domains are demarcated. In 
                                                 
1 a study of African American men who had syphilis and were not provided 
treatment although treatment was available in the broader medical community 
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particular, the obstetric scene is the hospital whereas the midwifery scene is the mother’s 
home. In obstetrical care, the birthing agent is the physician. Conversely, in midwifery, 
the agents are the mother, the fetus, and the father. Ropp continues to outline the dramatic 
differences and eventually shows how these different models figured into the legal 
prosecution of a midwife, determining the “evidentiary foundation” for the felony 
charges against her for adverse events in the deliveries of five babies over a two-year 
period. 
The present study is at the nexus of laboratory research science and medicine. 
During the hearings, Senator Tom Harkin (Stem Cell Research, part 3, 2000, p. 10) 
clearly stated the applied nature of embryonic stem cell research when he said that he did 
not believe in doing research just for the sake of research. Similar to the thermometer 
with imbedded purpose (mentioned a few paragraphs earlier), agency in applied research 
also has imbedded purpose. In fact, Burke (1969) says that in applied science, agency 
envelopes purpose so that what results is “purposive agency” (p. 286). Such an example 
in this study is the terminology of “therapeutic applications for stem cells” (Stem Cell 
Research, part 3, 2000, p. 7).  Alone, the embryonic stem cell can be a laboratory 
research tool potentially used for multiple purposes. However, with the addition of 
“therapeutic,” it takes on such a narrow purpose that the embryonic stem cell becomes 
only one type of agency. It is not a tool for basic research, in this case. It is only a 
therapeutic tool. Senator Harkin’s comment about the applied nature of scientific research 
introduces yet another aspect of the study topic: public policy. 
Public policy and the pentad. In addition to being about science and medicine, the 
debate about embryonic stem cell research is also about federal funding, which is 
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discussed in Congressional hearings. In their study of Congressional hearings, in which 
they analyze celebrity testimony, Christopher Darr and Harry Strine (1998) identify 
Congressional committee hearings as sites of rhetoric and choose Burke’s pentad to help 
explain the nuances of human behavior indicative of celebrities when they testify in the 
Congressional hearing setting. Darr and Strine find that the celebrities (agents) give voice 
to those without voice (act) in response to societal problems (scene) and that they use 
emotional appeals (agency) to do so.  
Public controversy and the pentad. In several of the pentadic studies, researchers 
have used Burke’s pentad to examine public controversy. In his study of Senator Ted 
Kennedy’s 1969 speech,2 David Ling (1970) demonstrates two dramas: the first drama of 
the actual accident he describes and the second drama of Massachusetts citizens deciding 
whether to allow him to remain in office. Foss (1979) analyzes the heated rhetoric 
surrounding the proposed Equal Rights Amendment to the Constitution. In her study, she 
examines the dramatistic elements of the visions, or mental versions of reality, that each 
side has created in response to the proposed amendment. In addition, Ronald Lee and 
Shawn Spano (1996) evaluate President Ronald Reagan’s speech on the Iran/Contra 
affair,3 finding that President Reagan used technical language do deflect responsibility as 
an agent. Instead, Lee and Spano suggest, President Reagan depended on the agency of 
the bureaucratic process to explain the errors of the Iran/Contra affair. Finally, another 
                                                 
2 The speech was addressed to the people of Massachusetts to explain the details 
of a car accident on Chappaquiddick Island in which the passenger in the car he was 
driving was killed. 
 
3Some controversy existed over whether the U.S. government had traded weapons 
for the release of U.S. citizens who had been held as hostages in Iran and whether funds 
from a sale of arms to Iran were sent to rebels (contras) in Nicaragua.    
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pentadic analysis examines a public controversy as played out in the Supreme Court. In 
his analysis of discourse in Korematsu v. United States, Clarke Rountree (2001) looks at 
pentadic elements across time and among individuals. With this method, Rountree 
expands the usual practice of analyzing one set of pentadic terms. This expanded 
approach, what Rountree calls multipentadic analysis, has influenced the methodology of 
the present study and is explicated below. 
Multipentadic analysis. Multipentadic analysis is the identification of more than 
one pentad and the relationships within and between them. This type of analysis is 
appropriate for the present study because it serves “rhetorically complex” discourse well 
(Rountree, 2001, p. 2). Rountree (2001) suggests that viewing pentads in a linear way 
may show that certain early acts shape the interpretations of later acts. In an online 
discussion group about his proposal of multipentadic analysis, he states the following: 
 I recommend that rhetorical critics look for how the construction of one act (one 
pentadic set) reverberates across the construction of others (other acts as a 
connected series, a group, or an arrayed set). The pentad can become a quite 
precise instrument for analysis when such multiple interactions are tracked down. 
(Rountree, “Thanks to Ed,” 2001, paragraph 2) 
 
 This study follows Rountree’s conclusion that “The number or ratios analyzed 
should be determined by the text under study, since some rhetors may ignore certain 
terms and ratios altogether” (p. 23). The individual text yields its own ratio trends.  
In traditional pentadic analysis, ratios are constructed on the basis of the internal 
elements such that a particular scene may have motivated a particular act. In the case of 
Korematsu vs. the United States, traditional pentadic analysis might have observed only 
the scene of the Supreme Court with the judges as agents who make decisions solely on 
the basis of the Constitution (agency). Comparing the judge-as-agent pentad with another 
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pentad illuminates the rhetorical complexity of the judges’ ruling. See Figure 2, which I 
created on the basis of the pentadic elements that Rountree describes. The figure 
demonstrates the rhetorical complexity that is revealed through multipentadic analysis:  
 
                                  
Part 1 
 
Figure 2. Pentadic sets as described by Rountree in Rountree, C. (2001). Instantiating 
“The Law” and its dissents in Korematsu v. United States: A dramatistic analysis of 
judicial discourse. Quarterly Journal of Speech, 87, 1-24. Part 1, pentadic set of judges 
(agents) making decision with “most rigid scrutiny” (agency). Part 2, pentadic set of 
commander (agent) making decision with military expertise (agency). Part 3, pentadic set 




                    
Part 2 
 




Figure 2. Pentadic sets as described by Rountree in Rountree, C. (2001). Instantiating 
“The Law” and its dissents in Korematsu v. United States: A dramatistic analysis of 
judicial discourse. Quarterly Journal of Speech, 87, 1-24. Part 1, pentadic set of judges 
(agents) making decision with “most rigid scrutiny” (agency). Part 2, pentadic set of 
commander (agent) making decision with military expertise (agency). Part 3, pentadic set 
of judges (agents) making decision with commander’s military necessity (agency). 
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Pentad 1 illustrates the judges’ position before the judges have made a decision. 
Pentad 2 represents the decision that the military made in arresting the plaintiff in the 
court case. Pentad 3 shows the structure of the final judicial decision. The final pentad 
shows that the two other pentads have commingled so that the final decision appears to 
be based on the military necessity (new agency in judges’ pentadic set/ old purpose in 
commander’s pentadic set) instead of scrutiny of the law or “the most rigid scrutiny.” 
This new agency makes the commander the implicit agent of the judicial act. If the 
analysis had been based on the first pentad alone, the role of the military would have 
been absent. A focus on the second pentad would have seemed odd in a judicial case 
since it is solely about the military aspect of the case. The final pentad illuminates the 
complexity of the situation, and because the other two pentads are shown, the analyst can 
see the history of the drama and its operative parts. 
Whereas military expertise was paramount in the judicial decision that Rountree 
studies, scientific expertise serves the same highly regarded source of opinion in the 
federal debate about embryonic stem cell research. It takes only a cursory review of the 
texts to surmise that scientific expertise is similarly dominant in the testimony of the 
witnesses, especially among the supporters of the research. However, application of the 
pentadic methodology allows the rhetorical elements and their interrelationships to rise to 
a higher profile.  
Rountree’s multipentadic analysis shows that not only was there more than one 
agent, but one agent actually replaced another. Rountree proposes his analytic approach 
for situations that have many rhetorical acts. The judicial discourse that he analyzes 
involved past acts, present acts of the Korematsu case, and future acts. The debate about 
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embryonic stem cell research is similarly complex in that witnesses discuss the past, 
present, and future involving the embryo or its derivatives. In the present study, as acts in 
the testimonies are identified and the scenes that called for the acts are located, it 
becomes evident quite quickly that the different acts often call for different scenes. If this 
is the case, the other elements of the pentad may be different as well. All of these new 
elements call for a multipentadic method. 
In her analysis of the movie “Fahrenheit 9/11,” Samantha Senda-Cook (2008) 
uses multipentadic analysis to elucidate the relationships between director Michael 
Moore’s construction of President George W. Bush and his construction of soldiers. 
According to Senda-Cook, Moore portrays President Bush as an agent who uses his 
presidential power to maintain his own wealth and that of his contacts at the expense of 
soldiers who live in poverty yet act on their sense of duty to serve their country through 






                             
Part 1 
 
                               
Part 2 
 
Figure 3. Pentadic sets as described by Senda-Cook in Senda-Cook, S. (2008). Fahrenheit 
9/11's purpose-driven agents: A multipentadic approach to political entertainment. KB 
Journal, 4. Part 1, pentadic set of Michael Moore’s construction of George Bush. Part 2,  
pentadic set of Michael Moore’s construction of soldiers. 
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Senda-Cook (2008) says that Moore juxtaposes the pentads, especially 
emphasizing that President Bush and the soldiers are at cross purposes. She suggests that 
the dominant ratio in the Bush pentad is purpose-agent and that the dominant ratio in the 
soldier pentad is purpose-scene. On the one hand, substantial financial gain and the 
maintenance of power were the motivations of President George W. Bush’s action. On 
the other hand, the soldiers’ motivating purposes of maintaining patriotic duty and family 
obligations actually maintained their families’ poverty. Senda-Cook also comments that 
the soldiers or former soldiers were only trained for military jobs and, thus, did not have 
the requisite skills for the civilian workforce.  
Senda-Cook’s (2008) study observes the rhetorical complexities of one text, 
although the analysis is of two agents (or a group of agents): President Bush and the 
soldiers. Similar to her study, my study compares the pentads of different actors. 
However, like Rountree’s study, which takes into consideration the past, present, and 
future, my study also observes how change occurs in a linear way, as Rountree suggests. 
Furthermore, the present study extends multipentadic analysis by focusing on more texts 
and more actors than even Rountree considered. In my study, I observe how each witness 
develops the drama of the embryo and how groups develop the drama. With the many 
scenes, acts, agents, agencies, and purposes represented in the debate texts, the situation 
under study is, indeed, rhetorically complex and an appropriate test case for Rountree’s 
multipentadic method. 
Conclusion 
Witnesses in the debate about federal funding for embryonic stem cell research 
testified at Congressional hearings to state their opinions about what the embryo should 
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be. In the testimonies, the embryo is transformed from an entity used for one medical 
purpose to an entity to be used for multiple medical purposes. The present study shows 
how the discourse of embryo science is expanded through an expanded definition of the 
embryo. In the following chapter, I describe the methodology for analyzing the prepared 
statements on the basis of Burke’s pentad.  
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Chapter 3:  Methodology 
The study applies discourse analytic tools to pentadic analysis. In this study, the 
term discourse analysis means the systematic identification of categories of interest. 
Kenneth Burke’s theory of pentadic analysis was described in Chapter 2, but in this 
chapter I describe how traditional methods of discourse analysis were modified to 
accommodate Burke’s pentadic theory, and I provide the particular steps in the process of 
pentadic analysis.  
The multipentadic methodology of the present study was devised on the basis of 
Rountree’s (2001) emphasis on viewing acts in a linear way in order to understand how 
early acts and the other pentadic elements might affect later pentadic elements. He 
studied the majority opinion and minority opinion in the Supreme Court case Korematsu 
v. United States. Each opinion represented the views of the justices who ruled in a certain 
way. In his study, Rountree analyzed ratios within pentadic sets and between pentadic 
sets, looking for ways that different pentads related to each other. Most pentadic analyses 
analyze only the ratios within a pentadic set. My corpus is different in that the 
stakeholders in the embryonic stem cell debate did not offer one cohesive document that 
would represent their views. To replicate the sense of cohesion, I analyzed the documents 
by stakeholder groups. The Results chapter includes quantitative analyses of the views 
represented in the stakeholder groups. Because the stakeholders were invited to the 
hearings not just because of their status as citizens but because they had some stake in the 
proceedings, I organize my findings by those who shared the same interests in the 
proceedings. Also, although a substantial part of the methodology was designed with 
multipentadic analysis in mind, the basic framework for the present study was Sonja 
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Foss’s (2009) method for pentadic criticism. In the sections below, I explain how the 
methodology for the present study follows Foss and where it deviates. 
Foss states that pentadic criticism is executed in four steps: 
1. Formulate a research question and select an artifact1 . 
2. Select a unit of analysis. 
3. Analyze the artifact by labeling the terms and identifying the dominant term. 
4. Write the critical essay. 
The method followed in the present study was the following: 
1. Formulate a research question and select an artifact (Foss, 2009). 
2. Select units of analysis (Foss, 2009). 
3. Analyze the artifact (Foss, 2009). 
a. Label terms (Foss, 2009; Huckin, 2004) and organize into pentadic sets 
(Rountree, 2001). 
b. Group repeating topics (Auerbach & Silverstein, 2003).  
4. Create master pentadic sets by organizing all pentadic elements (grouped by 
topic) around the act with which they are associated. 
5. Compare the master pentadic sets chronologically (in the order of the acts) across 
types of witnesses to find the most pronounced ratios (Rountree, 2001). 
  
Formulate a Research Question and Select an Artifact 
As stated in the Introduction, my research question queries the rhetorical process 
by which an embryo becomes or does not become a medical treatment in the 
 
1 Artifact is Foss’s term for the text being studied. 
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Congressional hearing arguments both pro and con. To answer the question, I used 
prepared statements from Congressional hearings on federally funding embryonic stem 
cell research.  
Characteristics of the corpus. The corpus comprises 47 prepared statements in the 
federal debate about embryonic stem cell research funding from 1998 to 2001. In August 
of 2001, President Bush established his directive that restricted federal funding for 
embryonic stem cell research. Limiting the study to pre-directive discourse focuses the 
study on the kinds of arguments that are used to shape policy in the absence of an 
existing policy. By focusing on pre-directive documents, this study also yields insight 
into how new scientific ideas are discussed in the public domain.  
Five sets of hearings were held before President Bush’s directive. However, only 
four were available to the public in print form at the time of this study: 
1. Stem Cell Research, Part 1. Senate Hearing 105-939. Hearings before a 
Subcommittee of the Committee on Appropriations. United States Senate. One Hundred 
Fifth Congress. Second Session. Special Hearing. December 2, 1998; January 12, 1999; 
January 26, 1999. Washington, D.C. 
2. Stem Cell Research, Part 2. Hearing before a Subcommittee of the Committee 
on Appropriations. United States Senate. One Hundred Sixth Congress. First Session. 
Special Hearing. November 4, 1999. 
3. Stem Cell Research, Part 3. Senate Hearing 106-413. Hearings before a 
Subcommittee of the Committee on Appropriations. United States Senate. One Hundred 
Sixth Congress. Second Session. April 26, 2000; September 7, 2000; September 14, 
2000. 
4. Opportunities and Advancements in Stem Cell Research. Hearing on Criminal 
Justice, Drug Policy, and Human Resources of the Committee of Government Reform. 
House Hearing 107-38. House of Representatives. One Hundred Seventh Congress. First 
Session. July 17, 2001. 
I grouped statements based on the witness’s policy preference (whether for or 
against federal funding of embryonic stem cell research) and interest as a witness. See 




Figure 4. Witness types in corpus. 
 
When the witness was both a patient and a representative of an advocacy group, I 
assigned the witness to an advocacy group because the witness spoke for others as well. I 
have included 27 statements from supporters and 20 statements from opponents. Some 
witnesses testified more than once. Because I was interested in how the arguments 
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developed over the course of the debates, I analyzed all of their statements as separate 
statements.  
Some of the documents in the hearing record were items of correspondence 
between individuals to clarify points that had been discussed in a previous hearing. I 
eliminated these from the corpus because they addressed very minute details less 
important to the overall argument of the proceedings. For instance, letters between 
Congressman Souder and the acting director of the NIH, Ruth Kirschstein, addressed 
whether the scientific literature included citations about clinical applications of 
embryonic stem cell research. I also eliminated documents that did not indicate 
preference regarding federal funding of embryonic stem cell research. I used each 
witness’s statement of preference in order to categorize statements as either supporter or 
opponent statements. See Table 1 for a list of witnesses. 
 
Table 1 
Witness List  
 Witness Stmt 
Letter/
Memo Position Stakeholder Type
1 Snowflakes Embryo Adoption 
Program    
Opponent Other Organization 
2 Christian Legal Society     Opponent Religious Organization 
3 Congress Mark Souder    Opponent Elected Official 
4 Congressman Chris Smith     Opponent Elected Official 
5 Congressman Dick Armey    Opponent Elected Official 
6 Congressman Jay Dickey     Opponent Elected Official 
7 David Prentice 1st  Opponent Scientist 
8 David Prentice 2nd  Opponent Scientist 
9 Dr. Frank Young   Opponent Other Organization
10 Anton Lewis Usala   Opponent Scientist 
11 C. Christopher Hook   Opponent Scientist 
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Table 1 
Witness List  
 Witness Stmt 
Letter/
Memo Position Stakeholder Type
(Continued) 
12 Human Life Advocates  (m) Opponent Other Organization
13 Micheline Mathews Roth   Opponent Scientist 
14 John and Lucinda Borden     Opponent Nuclear Family 
15 Marlene Strege     Opponent Nuclear Family 
16 Nathan Salley     Opponent Patient 
17 Richard Doerflinger     Opponent Religious Organization 
18 Russell Saltzman     Opponent Patient 
19 Senator Sam Brownback     Opponent Elected Official 
20 Mary Jane Owen   Opponent Religious Organization 
21 Singer Sisters    Supporter Patient 
22 Alliance for Aging Research    Supporter Patient Advocacy Group  
23 Christopher Reeve    Supporter Patient 
24 Congressman Elijah Cummings    Supporter Elected Official 
25 Congressman Henry Waxman    Supporter Elected Official 
26 Congresswoman Carolyn Maloney    Supporter Elected Official 
27 Congresswoman Jan Schakowsky    Supporter Elected Official 
28 Juvenile Diabetes    Supporter Patient Advocacy Group  
29 Parkinsons Action Network    Supporter Patient Advocacy Group  
30 Senator Dianne Feinstein    Supporter Elected Official 
31 Senator Orrin G. Hatch    Supporter Elected Official 
32 Senator Strom Thurmond    Supporter Elected Official 
33 Senator Tom Harkin    Supporter Elected Official 
34 Thomas Okarma     Supporter Scientific Company 
35 Allen Spiegel & Gerald Fischbach    Supporter Scientist 





37 Darwin Prockop     Supporter Scientist 
38 Gerald Fischbach     Supporter Scientist 
39 Harold Varmus   1st  Supporter Scientist 
40 Harold Varmus  2nd  Supporter Scientist 
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Table 1 
Witness List  
 Witness Stmt 
Letter/
Memo Position Stakeholder Type
(Continued) 
41 James Thomson     Supporter Scientist 
42 John Gearhart     Supporter Scientist 
43 Maria Freire     Supporter Scientist 
44 Michael West     Supporter Scientific Company 










47 American Society for Cell Biology 
3rd   





Selection and procurement of the artifacts. Each hearing had “stem cell” in the 
title. A search of Congressional hearings yielded hearings on other types of stem cell 
research as well, such as human cord blood stem cells, but these results were excluded 
because they were outside the scope of the primary research question. The simultaneous 
search of the Lexis Congressional database of the terms “stem cell” and “hearing” 
yielded 19 results, 13 of which contained the term “stem cell” in the title. Types of stem 
cells other than human embryonic stem cells do not share the same level of controversy. 
While there might have been additional hearings that fit the search criteria, the hearings 
referenced in this study were the only ones available via GPO Access, the online 
repository of the U.S. Government Printing Office. A search was also completed using 
the Government Publications Index (Marcive). When possible, the artifacts were 
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downloaded as text files. Several statements were scanned into the official record. In 
these instances, I retyped the text. 
Select Units of Analysis 
 Within the artifacts, I identified small chunks of text to make the massive corpus 
of 58,397 words more manageable. To do this, I isolated the portions of each artifact that 
referred to the in vitro embryo or one of its derivatives2. The isolated texts were complete 
sentences and, in some instances, a paragraph or more. I then determined the units of 
analysis in accordance with Foss’s (2009) prescription that, in pentadic criticism, the 
pentadic terms (i.e., act, scene, agent, agency, and purpose) are the units of analysis. A 
unit could have constituted one word or several sentences.  
Beyond the general terms act, scene, agent, agency, and purpose, I narrowed the 
pentadic terms to apply only to matters involving the in vitro embryo so that the 
following questions were used to define the units of analysis:  
 
Table 2 
Pentadic Elements and Questions 
Pentadic Element Question 
Act What is explicitly done to the in vitro embryo or its derivatives? 
Scene What is the physical location, background, or situation regarding 
the in vitro embryo or its derivatives?  
Agent Who performed the act regarding the in vitro embryo or its 
derivatives? 
Agency What means or materials are used to perform the act regarding the 
in vitro embryo or its derivatives?  
Purpose Why was the act regarding the in vitro embryo or its derivatives 
done? 
 
                                                 
2 Derivatives of the in vitro embryo were pluripotent stem cells, embryonic stem 
cells, child, tissue, and organs. When “stem cell” referred to a derivative of the embryo, it 
was also noted. 
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Analyze the Artifacts 
  Labeling Terms. The units of analysis were labeled whenever applicable, but 
some portions of the artifacts relevant to the embryo or its derivatives did not fit neatly 
into the pentadic categories. When this occurred, I made notes about the findings that 
explained the exceptions to the methodology, why those parts of the corpus were worth 
considering and why the portion of the artifact did not fit neatly into the categories. After 
labeling all of the documents, I revisited the notes to determine if I could assign the text 
to a category of the pentad. If I could not, I simply refrained from including the text with 
the coded categories.  
To ensure that units were labeled consistently and reasonably, I had a second 
person label the terms. I then compared my labeled text and the labeled text of the second 
person to assess the percentage of agreement. I achieved 80% agreement for items coded 
before proceeding with the analysis. Although Foss (2009) does not call for a second 
person to label the terms, I believe the additional step increased the rigor in parsing the 
text into units of analysis for this study. However, even in using discourse analysis 
methods, I adapted them to Burke’s units of analysis.  
Huckin (2004) recommends that categories of text be labeled one pass at a time. 
Thus, in the application of the pentad, one pass would be for act, one for scene, and so 
on. Although the goal of this approach is to yield consistent results, the opposite would 
be true in the case of coding for pentadic terms as the pentadic terms are definable only in 
their relation to each other and, thus, discernible only when viewed as a pentadic whole. 
When the labeled segments are viewed together, their roles in the pentad becomes 
apparent.  
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To illuminate the differences between the two approaches—labeling over multiple 
passes vs. one pass —I offer an example from my corpus and labeling examples using 
both methods: 
The groundbreaking research done by Dr. Thomson and Dr. Gearhart shows 
tremendous promise. From enabling the development of cell and tissue 
transplantation, to improving and accelerating pharmaceutical research and 
development, to increasing our understanding of human development and cancer 
biology, the potential benefits of their work are truly awe-inspiring. (Senator Tom 
Harkin, Stem Cell Research, part 3, 2000, p. 10) 
 
If I were coding the artifact in separate passes, I might first label all the acts that 
directly involve the embryo or its derivative. The following would be the result. 
Table 3  
Example of Acts in Corpus 
Act Scene Agent Agency Purpose 
Research     
Cell and Tissue Transplantation     
Pharmaceutical research and 




However, if I were coding all pentadic elements at one, I would instead code the artifact 
in the following manner: 
Table 4 
Example of an Act and Corresponding Purposes 
Act Scene Agent Agency Purpose 
Research    • Cell and tissue transplantation 
 
• Pharmaceutical research and 
development 
 
• increase our understanding of human 




In this usage, pharmaceutical research and transplantation are purposes, and not 
acts, and yet coding allows me to see that these are potential future acts. In other words, 
purposes in this argument may later be transformed into acts if embryonic stem cell 
research progresses to those points. The same knowledge also allows me to see that 
medical research is typically conducted as part of a very strategic program of inquiry that 
has specific outcomes for treatment in mind. My example suggests that the expectation 
that research end in medical application makes the embryo a treatment. Also, I might find 
in the corpus that research is no longer discussed as an intermediary step to medical 
application. For instance, transplantation may be discussed in a way that suggests almost 
immediate reality instead of the future act that it is. In such a case, transplantation would 
be coded as an act instead of a purpose. 
The examples that I have provided show that the categories are not static and do, 
indeed, depend on the context in a way that requires the entire situation to be considered 
together during the labeling process. This approach aligned with the spirit of Burke’s 
pentad in that the importance of relationships is the focal point.  
Organize into pentadic sets. A pentadic set is a grouping of the five pentadic 
terms that fit together. Although Burke (1969) does not use the term “pentadic set,” he 
does set forth examples of how the terms fit: 
The hero (agent) with the help of a friend (co-agent) outwits the villain (counter-
agent) by using a file (agency) that enables him to break his bonds (act) in order 
to escape (purpose) from the room where he has been confined (scene). (p. xx) 
 
Whenever I identified pentadic categories, I always labeled them, even if other 
elements of the pentadic set were not present. As I identified terms, I attempted to 
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complete the pentadic set with other details in the document. However, no implied text 
was labeled as being consistent with the terms.  
Group repeating topics. After labeling, Foss’s (2009) next step is to identify the 
dominant term. According to Foss, one pentadic term may be central to all the others. For 
instance, in the present study, purpose might be the dominant term that determines the 
act, scene, agent, and agency. Foss’s approach in locating the dominant term may be 
especially revealing when the artifact has one pentadic set. However, focusing on one 
dominant term may be too limiting for analysis of several pentadic sets that may interact 
in myriad ways. Thus, to accommodate the different pentadic sets and witness types in 
the present study, I used Rountree’s approach of multipentadic analysis. To ensure that 
the data are consistent across documents, I grouped units of analysis on the basis of the 
similarity of their topics. For instance, I grouped research acts together, purposes related 
to cures together, scenes related to family life together, and so on. This step is similar to 
the grouping of repeating ideas described by Carl Auerbach and Louise Silverstein in 
Qualitative Data: An Introduction to Coding and Analysis (2003), in which findings are 
organized into repeating ideas as a preliminary step in analyzing data. When a topic was 
quite similar to another, the topics were merged. 
Create master pentadic sets. To replicate Rountree’s use of documents that spoke 
with one voice, I created pentadic sets that encompassed all of the pentadic elements 
related to a particular act within a particular group. For instance, if supporters discussed 
research, I created a research-themed pentadic set and included in the set all of the agents, 
agencies, scenes, and purposes that had been coded with research. For example, if lab 
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scenes were associated with research, lab scenes were put into the master pentadic set for 
research. 
Creating the master pentadic set allowed me to compare the pentadic elements as 
the embryo and its derivatives moved through the processes that stakeholders desired for 
them. I could look within each master pentadic set to determine priority ratios and 
between master pentadic sets to determine shifts in priorities. In this way, I could see if a 
purpose in one master pentadic set became an act in another or if a purpose was dropped 
altogether in lieu of another. 
Compare master pentadic sets. Multipentadic analysis calls for the most 
pronounced ratios in the artifact. According to Rountree (2001), the number of ratios 
should be determined by the artifact being studied, and some pentadic categories may not 
be considered at all in the analysis. Looking for multiple ratios is in keeping with Burke’s 
(1969) comments: 
We want to inquire into the purely internal relationships which the five terms bear 
to one another, considering their possibilities of transformation, their range of 
permutations and combinations—and then to see how these various resources 
figure in actual statements about human motives. (p. xvi) 
 
To identify the most pronounced ratios, I first organized the coding results using 
QSR Nivo 9, a qualitative research software package. With the results organized by 
pentadic element and topic and ultimately by master pentadic sets, I was able to visually 
compare the master pentadic sets to identify trends and anomalies in ratios between and 
among sets. After observing these patterns, I was able to address my ultimate question—
whether the ratios move the embryo closer to categorization as a treatment tool or further 
away from such categorization, as potential human life. 
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Coding Procedure for Second Coder 
The second reader was given the following instructions to select the documents 
that he would label. In order to avoid researcher bias, I chose not to provide the second 
reader with a representative sample. Stratified random selection was used by the second 
reader. The following instructions were given to the second reader: 
1. Choose 1 document from each category described below: 
a. Against – Scientist 
b. Against – Association, Group, Company, or Organization 
c. Against – Elected Official 
d. Against – Patient 
e. Against – Nuclear Family  
2. Choose 2 documents from each category described below: 
a. For – Scientist 
b. For – Elected Official  
c. For – Patient  
d. For – Association, Group, Company, or Organization 
3. Mark your selections in the last column of the table. 
4. Give the piece of paper with your selections to the first reader. 
Table 5 
Table Given to Second Coder for Selecting Documents to be Coded 
 Position Stakeholder Type Mark “X” for your selections
1 Opponent Other Organization   
2 Opponent Religious Organization  
3 Opponent Elected Official  
4 Opponent Elected Official  
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Table 5 
Table Given to Second Coder for Selecting Documents to be Coded 
 Position Stakeholder Type Mark “X” for your selections
(Continued) 
5 Opponent Elected Official  
6 Opponent Elected Official  
7 Opponent Scientist  
8 Opponent Scientist  
9 Opponent Other Organization  
10 Opponent Scientist  
11 Opponent Scientist  
12 Opponent Other Organization  
13 Opponent Scientist  
14 Opponent Nuclear Family  
15 Opponent Nuclear Family  
16 Opponent Patient  
17 Opponent Religious Organization  
18 Opponent Patient  
19 Opponent Elected Official  
20 Opponent Religious Organization  
21 Supporter Patient  
22 Supporter Patient Advocacy Group   
23 Supporter Patient  
24 Supporter Elected Official  
25 Supporter Elected Official  
26 Supporter Elected Official  
27 Supporter Elected Official  
28 Supporter Patient Advocacy Group   
29 Supporter Patient Advocacy Group   
30 Supporter Elected Official  
31 Supporter Elected Official  
32 Supporter Elected Official  
33 Supporter Elected Official  
34 Supporter Scientific Company  
35 Supporter Scientist  
36 Supporter Scientific Professional Organization  
37 Supporter Scientist  
38 Supporter Scientist  
39 Supporter Scientist  
40 Supporter Scientist  
41 Supporter Scientist  
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Table 5 
Table Given to Second Coder for Selecting Documents to be Coded 
 Position Stakeholder Type Mark “X” for your selections
(Continued) 
42 Supporter Scientist  
43 Supporter Scientist  
44 Supporter Scientific Company  
45 Supporter Scientific Professional Organization  
46 Supporter Scientific Professional Organization  
47 Supporter  Scientific Professional Organization  
 
 
I gave each a number and saved the statement electronically with the number as 
the file name. I made a table that matched each number with a description of the 
corresponding witness. From the table, a second coder selected 8 numbers that 
corresponded with supporter statements and 5 numbers that corresponded with opponent 
statements. The selections also represented all of the categories of stakeholders and both 
positions (supporter and opponent). Together, the selections represented approximately 
25% of the statements in the corpus.  
The next chapter discusses findings from the coding. 
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Chapter 4: Results1 
The proposal for this analysis called for the coding of 51 documents. Upon closer 
examination of the documents, I eliminated 4 because they were letters to individuals and 
not documents submitted for testimony and the official transcript. Thus, I analyzed 47 
documents. Twenty-seven (57%) of the documents represent supporters of federal 
funding for embryonic stem cell research. The remaining 20 (43%) are statements from 
opponents. Also, the documents are representative of the following witness types, 
predominantly either scientists (13, 28%) or elected officials (13, 28%) and second, 
various associations or groups (15, 32%: 3 patient advocacy groups [6%], 4 scientific 
professional organizations [9%], 3 religious organizations [6%], 2 scientific companies 
[4%], and 3 organizations deemed as “other” [6%]). Individual patients (4, 9%) and 
nuclear families (2, 4%) were a minority. (Table 6 cross-references witnesses’ positions 










1 Because of rounding, some total percentages may exceed 100%. Also, unless 
otherwise noted, the denominator equals 47 in percentage calculations. 
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Table 6  
Witness Type by Position   
  Position 
Witness Type Supporter Opponent 
      
Elected Official 8 5 
Scientist 8 5 
Patient 2 2 
Nuclear Family 0 2 
Patient Advocacy Group 3 0 
Scientific Professional 
Organization 4 0 
Religious Organization 0 3 
Other Organization 0 3 
Scientific Company 2 0 
 
 
When the witness was both a patient and a representative of an advocacy group, I 
assigned the witness to an advocacy group because the witness spoke for others as well. 
When the witness was both a scientist and a representative of a professional society of 
scientists, I categorized the testimony as scientific professional organization. As a final 
note about the reporting of data, the number of documents should not be correlated with 
number of witnesses since 4 (9%) witnesses testified twice. Thus, the data are reported as 
number of documents per category. 
First, I coded all of the pentadic elements by answering the questions in Table 2. 
The act is central to Burke’s pentadic method; thus, all acts were coded first. The “act” 
pinpoints the action taken that directly involves the embryo. For example, an act might 
have been “research,” i.e., in this case the embryo is referenced as necessary to research. 
Some events that could have been coded as acts were dependent on another act and, thus, 
were considered secondary acts and coded as the primary act’s scene. Considering the 
same act of “research,” a secondary act (scene) might have been “funding.” Although 
funding can be an act on its own, it is not done directly to the embryo; therefore, funding 
was part of the environment in which the act of research occurs. See the example below 




Figure 5. Examples of pentads in corpus with funding in the scene. 
 
After coding the acts, I coded the scenes, agents, agencies, and purposes, pentadic 
element by element. For each instance of a pentadic element, the entire pentadic set was 
coded using NVivo qualitative research software so that the sets could be cross-
referenced in the analysis.  
With so many potential acts in the corpus, locating the act of interest was quite 
challenging. After several attempts to locate the act directly related to the embryo, I 
finally arrived at the act of interest by focusing intently on the act question. When I had 
the second coder code for acts, he experienced similar difficulty, especially considering 
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his unfamiliarity with the corpus. Determining the appropriate act taking place is 
essential to identifying the other elements. After two attempts at coding, the second coder 
was unable to consistently locate the act of interest; however, his coding patterns 
indicated that he understood the relationships between the act and each of the other 
pentadic elements. For instance, he might code funding as the act, federal government as 
the agent, and research as the purpose, whereas my focus was the act of research as the 
starting point. To reconcile the coder’s understanding of the pentad with my focus on 
particular kinds of acts, I highlighted the acts of interest in the texts. After this, he was 
able to locate the other pentadic elements. Although this method deviates from my initial 
plan, it allowed me to maintain the integrity of Burke’s pentadic methodology by 
verifying the relationships used for the ratios. After the second coder’s third attempt at 
coding, I manually counted 474 units of agreement (i.e., the pentadic elements) and 112 
units of disagreement between the codings of the first and second coders, for an 
agreement percentage of 81% (474/586).  
One goal of the study was to determine the order of acts that had occurred in the 
past regarding the embryo and that witnesses supported for future practice. To make this 
determination, I filtered the acts according to the witness’s desire, the acts the witness 
proposed for the embryo. In the study, such acts are categorized as Desired Acts. Acts 
that the witness seemed to view as neutral were coded as Desired Acts as well. The 
scenes, agents, agencies, and purposes associated with Desired Acts were categorized as 
Desired Scenes, Desired Agents, Desired Agencies, and Desired Purposes. Thirty-seven 
(79%) of the 47 documents in the corpus had Desired Acts (27 [all] [57%] supporters and 
10 [21%] opponents).  
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The acts in each group were organized into several themes on the basis of topic 
similarity. The next few pages elaborate on the themes for Desired Acts, their associated 
pentadic elements, and the pentadic sets that they suggest. The themes for Desired Acts 
are IVF Process, Post-Infertility Treatment, Research Lab, and Treatment. (See Tables 
A1-A17 in the Appendix for a breakdown of themes by position and witness type and for 
a list of the types of acts included in each theme.) 
Using NVivo qualitative research software, I ran queries of each type of act and 
the agents, agencies, scenes, and purposes that corresponded with it. (See Table A8 in the 
Appendix for all major pentadic sets.) The results constituted a pentadic set. Two 
versions of pentadic sets were created when applicable, one for each position—pro or 
con. The research acts only included witnesses who were in favor of using the embryo or 
its derivatives for research. Twenty-six pentads were analyzed. In the analysis, I reviewed 
the pentadic elements in each set to ascertain where the embryo was, where it was going, 
what medical attributes were attached to it and what pentadic ratios were used in each 
case to position the embryo. However, the pentadic analysis was necessarily selective 
because of the extensive number of pentadic elements that were identified for each 
pentadic set. Pentadic elements were identified and cross-referenced a total of 1,846 
times. Nonetheless, the analysis illuminates movement of the embryo and its derivatives, 
per the goals of the study. 
IVF Process  
IVF Process Acts are acts that reference (1) the use of in vitro technology in the 
fertilization of an egg, creation of a blastocyst, or creation of an embryo and/or (2) the 
implantation of an embryo that has been created by IVF means. (See Table A9 in the 
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Appendix for the pentadic sets included in this theme.) IVF Process Acts were coded in 
14 documents (30%) (10 supporters [21%]: 3 elected officials [6%], 3 scientists [6%], 2 
scientific companies [4%], 1 patient [2%] advocacy group, and 1 scientific professional 
organization [2%]; 4 opponents [9%]: 2 nuclear families [4%], 1 religious organization 
[2%], and 1 organization classified as “other” [2%]). In the corpus, the mention of IVF 
technology also functioned in the roles of agency, purpose, and scene. Therefore, the 
number of documents with comments on IVF technology may exceed the number 
reported for IVF Process Acts. 
Embryo creation. In the IVF Process Act, both supporters and opponents agree 
that the object of interest—the blastocyst, fertilized egg, or embryo—is created in this set 
of acts. (See Figures 6-7).  However, they use varied language to describe just what is 
created. One document, from a supportive scientific professional organization, states that 
the blastocyst used in research was fertilized by IVF. The act of blastocyst creation was 
necessary for the scene of the work of Dr. Thomson (the scientist who first isolated 
human embryonic stem cells in 1998) in isolating stem cells, indicating a scene/act ratio. 
It was the scene that called for the act.  
Two documents (4%), both from supporters of the research (1 scientist [2%] and 1 
elected official [2%]), note that IVF was used to fertilize an egg. The ratio of act/purpose 
(egg fertilization/infertility treatment) indicates medical relevance. However, this is a 
different medical relevance than that indicated by the scene/act ratio of NIH Guidelines 






Figure 6. Pentadic set of embryo creation (supporter).  
 
The Guidelines that NIH (2000) proposed to regulate federally funded embryonic 
stem cell research stipulate that the source of the embryonic stem cells, the embryo, must 
have been created for the purpose of infertility treatment. This scenic component that 
NIH provides also applies a medical framework to the embryo. The ratio of 
scene/purpose (NIH/infertility treatment purpose) is actually a turning point for the 
embryo in the medical domain. Before the involvement of the NIH, the ex utero embryo 
is applicable to one type of treatment—infertility treatment. The NIH Guidelines work 
powerfully in yet another way in the scene/purpose ratio. They state that the embryos 
used in federally funded research must be “in excess of clinical need.” In pentadic terms, 
they must have lost their purpose. So first, they must have been created for the purpose of 
infertility treatment, but also they must have lost that purpose. The NIH scene is a 
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medical signifier because of its mission, which broadens the context or scene for which 
the embryo is applicable. In part, the NIH (2009) mission involves applying knowledge
to “extend healthy life and reduce the burdens of illness and disability” (NIH Mi
section, para. 1). With the addition of the scene of NIH Guidelines, the embryo 
potentially has medical pertinence for people other than women who seek infertility





or disabilities. The following is a synopsis of the proposed NIH Guidelines 
(2000): 
been in excess of 
hout 




General Counsel used the “broadly accepted science-based definition of organism: an 
• The embryos used for stem cell derivation must have 
clinical need of women seeking infertility treatment. 
• The human embryonic stem cells had to have been derived wit
funding from the Department of Health and Human Services. 
• Investigators must provide docum
the stem cells from the embryo. 
The second criterion of federal funding listed here, first offered in 1999, was 
shaped by the legal opinion of Harriet Rabb (1999), at the time the General Counsel fo
the Department of Health and Human Services. Rabb had been asked to issue a legal 
opinion on whether federal funds could be used for research on human embryonic ste
cells per the Dickey-Wicker amendment. In describing the legal opinion, Dr. Harold 
Varmus, then director of the NIH, stated that federal funds could be used for research on
human pluripotent stem cells derived from embryos because the stem cells themselves 
were not embryos and they were not organisms per 45 CFR 46. Varmus noted that the 
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individual constituted to carry out all life functions” (Stem Cell Research, part 1, 1999, p. 
122). 
Although the present pentadic sets are grouped as IVF Process Acts, they do show 
variations. For instance, no agents are discussed in the pentadic sets for blastocyst 
creation and egg fertilization. Family agents (couples and parents) are discussed with 
embryo creation (2 opponent nuclear family witnesses [4%] and 1 supporter patient 
advocacy group [2%]). Actually, both the agent/act ratio and purpose/act ratio speak to 
the roles of family members in embryo creation and the benefit that they will receive 
from it. Supporters and opponents of the research use similar language in these ratios, but 
they differ in the discussion of medicine. The only medical term that the opponents use is 
reference to infertility clinics as agents (1 religious organization [2%]) and scenes (1 
religious organization [2%] and 1 nuclear family [2%]). So the act/agent ratio is 
suggestive of medical involvement. For instance, the memo submitted by the Christian 
Legal Society states that the infertility clinic creates human embryos. Supporters position 
details related to infertility treatment at scene and purpose. The scene of the infertility 
clinic provides the physical location of the act of creation. Additionally, as with the 
pentadic set for egg fertilization, the scenic element of NIH Guidelines (2000) reframe 
the creation of the embryo as being medically relevant to a broader range of people other 
that those seeking treatment for infertility (1 scientist [2%] and 1 scientific professional 
organization [2%]). 
For opponents, the IVF process is family centered (Figure 7). Although medical 
intervention is involved, evident in the involvement of the IVF clinic, the position of the 
embryo always remains within the context of the family. Family agents are involved, the 
 61
purpose of the act is to benefit families, and part of the scene suggests family. An 
opponent notes as the family scenic element the month and year of the conception of the 
embryos she adopted. The witness opted to use the term “conception” instead of 
“created” to describe the point at which the egg was fertilized. Conception connotes a 
biologically natural process and is the commonly used medical term describing the 
fertilization of the egg, whereas “created” connotes a wider range of developmental 
concepts, including Godlike and human activities, but not specifically one leading to 
birth. The pentadic structure of the opponents’ set suggests that the end of the embryo is 
in the family. Conversely, some of the supporters’ ratios in the IVF Process Acts leave 
open the possibility that the embryo may be used in another pentadic set—another act, 
scene, purpose, agency, and agent. The IVF Process Acts end with implantation of the 
embryo in the uterus of the initially intended recipient of treatment. The next phase of 
acts explores what occurs when the initial purpose vanishes.  
              
 
 
Figure 7. Pentadic set of embryo creation (opponent).  
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The ratios in the IVF Process Acts confirm that this grouping of acts should take 
the lead in the chronology of acts that may direct the embryo and/or its derivatives to 
become a treatment. The pentadic elements squarely position this grouping as the point of 
origin for the embryo, whether it is deemed a blastocyst, a fertilized egg, or an embryo. 
Also, the ratios in this set of acts demonstrate the embryo as a medical entity, whether 
intended for infertility or a broader range of conditions. 
Post-Infertility Treatment 
Most striking about the phase of acts after infertility treatment is the breadth of 
topics coded at each pentadic element. For instance, alongside the purpose of medical 
treatment “for thousands” is the purpose of helping others to have a child. Although the 
initial infertility treatment is over, the purpose of having a child persists. Additional 
topics include religious scene, science agent, future use purpose, medical treatment 
purpose, embryo agency, adoption scene, national scene, and more. This plethora of 
subjects seems to be an indicator of the witnesses’ attempts to define the debate about 
embryonic stem cells. Nonetheless, some witnesses do use the ratios to effect so that the 
next set of acts is Research Lab Acts. Still other witnesses divert attention from the 
research lab to define the embryo in another way, in the family context. 
Although some of the ratios among the IVF Process Acts point to medical use, 
other types of acts suggest intermediary steps between these acts and the eventuality of 
treatment acts. In the acts that occur in the period after infertility treatment, embryos that 
not implanted during IVF Process Acts can be frozen, discarded, adopted, donated, or 
obtained. They can be legally protected. Others may speak for them. Also, a massacre can 
be prevented on the embryos’ behalf. Most of these acts obviate further use of the 
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embryo, but when the embryos are adopted, donated, or obtained they may be involved in 
additional pentadic sets. 
Adoption. Nine documents (19%) are coded for adoption acts (2 supporters [4%]: 
1 elected official [2%], 1 patient advocacy group [2%]; and 7 opponents [15%]:2 elected 
officials [4%], 1 scientist [2%], 2 nuclear families [4%], 1 religious organization [2%], 
and 1 other organization [2%]).The supporters’ pentad is rather bare (Figure 8). It 
presents the agent/act ratio as specific to particular agents. For example, in the document 
from the Parkinson’s Action Network, president Joan Samuelson says that she is happy 
for the Strege family that they adopted a baby. However, she does not discuss embryo 
adoption as an option for others. With the scene/act ratio, Senator Orrin Hatch suggests 
that adopting an embryo would not have broad appeal and application because the 
embryo may transmit a disease to the adopting mother (scene) and because such acts are 







                   
 




Alternatively, the opponents’ pentad is marked for the preponderance of family 
details in each pentadic element (Figure 9). Scenes include children, home, pregnancy, 
adoption, a birth certificate, and a journal to document the “touching things” one adoptive 
daughter does. Agents include family references, the IVF clinic, and human beings. 
Embryos (or former embryos) are even discussed as agents for the first and only time in 
the series of acts. Purpose includes uniquely familial qualities such as inheritance rights, 
adoption agreement, and naming. Essentially, the family elements in the opponents’ 
pentad paint a different picture than that presented in the supporters’ pentad. For 
example, a mother who adopts an embryo, Marlene Strege, uses the agent/act ratio when 
she says that any woman can carry any embryo. Strege’s ratio is in contrast to the 
act/ratio described in the last paragraph, which emphasized the limitations of embryo 
adoption. Also, documents in the opponents’ pentadic set distinguish embryo adoption 
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from embryo donation. Scenic elements such as a birth certificate, home, and stable 
families work with embryo adoption acts to mark the integration of the child into a 
family. Adoptive parents even go through a home assessment to qualify as an adoptive 
family. Witnesses mention this qualification process as one of the distinguishing 
characteristics between adoption and donation (the transfer of the embryo, through 
informed consent, to the ownership of someone other than the genetic parents). 
Adoption acts do not have a pentadic mechanism for moving the embryo on to 
another pentadic set. In fact, if any possibility of escape exists for the embryo, it will 




         
 




Donation. Donation is an act advocated by 10 supporters (21%) of the research (2 
elected officials [4%], 4 scientists [9%], 1 patient [2%], 2 scientific professional 
organizations [4%], and 1 scientific company [2%]) (Figure 10). None of the opponents 
used the term in their recommendations for what should happen to the embryo. The 
pentadic set adds an agent to the 2 that were in IVF Process Acts. Whereas, IVF Process 
Acts had family and IVF clinic agents, the current pentadic set adds donor agents. The 
donors (agent) naturally fit their matching acts of donating since inherent in the word 
donor is the act. Actually, although the family agents in this pentadic set are parents and 
couples, they function as donors by being affiliated with the act of donation. This 
act/agent ratio indicates movement of the embryo, but the direction is opaque without 
another pentadic element. 
Pairing donor (agent) with informed consent (agency) provides a mechanism for 
moving the embryo. However, it is the pairing of donor (agent) or donation (act) and 
research (purpose) that indicates the direction with clarity. Some witnesses connect 
donation (act) with stem cell derivation (purpose). Although the agent/purpose and 
act/purpose ratios just noted do not point to a treatment component, they do move the 
embryo along to the next act, Research Lab Acts. However, other ratios lead the embryo 
toward treatment. 
An act/purpose ratio elaborates on the medically expanded purposes that ended 
the previous phase of acts. Some witnesses say that by donating the embryo and not 
discarding it, the embryo could be used for “medical research to help millions of 
suffering individuals,” according to scientist Allen Fischbach and to “help save thousands 
of lives” (Opportunities and Advancements in Stem Cell Research, 2001, p. 107) 
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according to Christopher Reeve (Stem Cell Research, Part 3, 2000, p. 37). Also, the NIH 




         




Obtain. Four documents (9%) are coded in this pentadic set (1 supporter elected 
official [2%], 1 supporter patient [2%], 2 supporter scientific professional organization 
[4%]) (Figure 11). Like the agent/purpose and act/purpose in the donation pentadic set, 
the agent/act ratio (scientist/obtain) in the current pentadic set confirms that the embryos 
move next to the research lab. In fact, in this pentadic set, agency, purpose, and scene are 
consistent with scientific research. Thus, the possible ratios in this pentadic set predict the 
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research lab as the next stop for the embryo. Also, the scene/act ratio of time/obtain 
positions the pentadic set as being after infertility treatment and after the genetic parents 
or donors have decided not to implant the embryos.  
 
       
Figure 11. Pentadic set of obtain embryo (supporter). 
 
 
Research Lab  
All 27 support documents (57%) are coded at these acts (Figure 12). The 
agent/purpose ratio of donor/research, the act/purpose ratio of donate/research, and the 
agent/act ratio of scientist/obtain from the post-infertility treatment period usher the 
embryo to a phase of Research Lab Acts. Once in this phase, the embryo is potentially 
subject to a variety of acts (Table 12). Twenty-six of the documents (55%) in this phase 
refer to the act as “research.” However, several of the steps in the process of research are 
also discussed. In this section, I report on the steps in the process, which describe a 
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research protocol in two parts: preparation of undifferentiated embryonic stem cells and 
preparation of differentiated embryonic stem cells.  
Pentadic sets for first part of protocol. The preparation of undifferentiated 
embryonic stem cells has been demonstrated by Dr. Thomson. This protocol includes 
stem cell derivation (i.e., harvesting or isolating the stem cells) (Figure 13) and growing 
cells in culture (dissociating and replating the cells so that they can be immortalized 
[replicated indefinitely]). Through this protocol, the embryo transitions from an embryo 
(agency), to cells (agency), to a cell line (agency). Stem cell derivation is simply the 
process of obtaining the stem cells from the embryo. This act of derivation is usually 
discussed in one of two ways: (1) as a reference to Dr. Thomson’s achievement of stem 
cell derivation for the first time or (2) as a reference to what should be done before 
federal funds can be used for embryonic stem cell research. For the federally funded lab, 
stem cell derivation happens in the period after infertility treatment and after informed 
consent but before Research Lab Acts. 
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Figure 12. Pentadic set of research (supporter). 
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Figure 13. Pentadic set of derivation (supporter). 
 
Because of the act/agency ratios of derivation/embryo and growth/stem cells, 
agencies include cells, stem cells, stem cell lines, embryonic cells, embryonic stem cell 
lines, pluripotent stem cells, and more. (Many of the terms used for agency might apply 
to the same entity.) Although the cells are referred to variously as cells and cell lines, it is 
the cell line form that solidifies the cells as scientific material. Cell lines are defined as “a 
cell culture selected for uniformity from a cell population derived from a usually 
homogeneous tissue source” (Merriam Webster’s Online Dictionary). In other words, cell 
lines do not naturally occur in the body. The term “cell line” is applied to cells that have 
been nurtured in a laboratory environment. The culture scene, laboratory techniques 
(agency), science agent, and cell line (agency) all work together to characterize the 
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embryo derivative as research material. The stem cell line can be used in research 
(purpose) and, possibly, medical treatment (purpose). Specifically, one goal is to apply 
scientific acts to the scene of histocompatibility problems in order to have a product that 
is transplantable.  
Pentadic sets for second part of protocol. The second part of the research protocol 
includes differentiation (Figure 14), genetic manipulation of cells, establishment of new 
cell lines, and banking differentiated stem cells. Differentiation, mentioned in 11 
documents (23%), describes the process and event of an unspecialized cell becoming 
specialized (i.e., brain cell, skin cell, etc.). The differentiation pentadic set has many of 
the same features as the derivation pentadic set such as scene (NIH Guidelines [2000], 
funding, stages of the embryo, scientists’ opinion and scientific literature), scientist 
agents, stem cell and laboratory technique agencies, and medical purpose. They are also 
bound by hope in their scenes. In the Differentiation pentadic set, belief is part of the 
scene. One witness comments that in the short time since the discovery of embryonic 
stem cells, many uses have been conceived. This comment was also part of the scene. 
Another witness comments that the method (agency) of differentiation “remains to be 
elucidated.” Although the mechanism for differentiation needs to be elucidated, the 
confidence in its eventuality is emphasized with hope and belief. One witness expresses 
confidence in saying (scene) that “when scientists are able to specialize” they will be able 
to establish new cell lines. Another witness envisions a scene of a library of cells being 
established that will hold cells that have been genetically manipulated (act) to prevent 
immune rejection (purpose). 
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Figure 14. Pentadic set of differentiation (supporter).  
 
Sixteen (34%) of the 27 documents are coded for medical scene, and 26 
documents (55%) are also coded for medical purpose. The most dominant scene 
associated with Research Lab Acts is the set of NIH Guidelines (2000). Although 13 
documents (28%) are coded for research, clearly medical purpose is the more dominant 
concern. However, as Harold Varmus, then head of NIH, notes, “There is much to be 
done before we can realize these innovations” (Stem Cell Research, part 1, 1999, p. 9). 




Nineteen documents (40%) are coded for treatment acts. These acts include 
reference to some aspect of therapy (e.g., treating disease, transplanting cells, or repairing 
tissues) (Figure 15).  
               
Figure 15. Pentadic set of treatment (supporter).  
 
At this point, the embryonic derivatives are mechanisms for treatment, and they are 
products that can be sold as therapies in a commercial scene. In Research Lab Acts, the 
president of Geron Corporation commented that industry would only pursue research that 
would lead to treatments. In Treatment Acts, Dr. Thomson says that private companies 
will bring ES-based technologies to the marketplace. The ratio of agent/scene (private 
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companies or industry/the marketplace) works to make embryo derivatives applicable to 
the purpose of medical treatment.  
The account of acts that involve the embryo or its derivatives begins with the 
embryo’s creation in IVF Process Acts and ends in Treatment Acts with only the 
embryo’s derivatives in the form of cells or cell lines. The embryo has no inherently 
medical or research-related attribute. Nonetheless, the rhetorical use of several ratios 
present the embryo or its derivatives as appropriate for both research and medical 
environments. This chapter has reported the ratios that have framed the embryo as 
research and treatment material. The next chapter will discuss how the ratios are 
theoretically operable in accordance with Burke’s pentadic methodology. 
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Chapter 5:  Discussion 
The findings documented in the previous chapter lend themselves to a discussion 
of Burke’s approaches to definition (familial, contextual, and directional). In the section 
below entitled “Placement of the Embryo in the Debate,” I provide my first impressions 
of the role of the pentadic elements in the development of definitions for the embryo in 
the debate about federal funding for embryonic stem cell research. However, these first 
impressions lead to others that I then discuss in terms of Burke’s philosophies. The 
chapter is rounded out by an acknowledgement of the study’s limitations and suggestions 
for further inquiry.  
Placement of the Embryo in the Debate 
IVF process acts. In the IVF Process Acts, the embryo is described as something 
that is created (act) in an infertility clinic (scene) by means of IVF technology (agency), 
and carried out by clinic staff (agents) for infertility treatment (purpose). No matter how 
these pentadic elements are paired for ratios, they are all consistent with the infertility 
treatment scene by being obviously consistent with each other in the way that Burke 
(1969) describes in his analogy of the hand as the pentad: 
We have also likened the terms to the fingers, which in their extremities are 
distinct from one another, but merge in the palm of the hand. If you would go 
from one finger to another without a leap, you need but trace the tendon down 
into the palm of the hand, and then trace a new course along another tendon. (p. 
xxii) 
 
Dr. Harold Varmus describes IVF Process Acts in the context of Dr. Thomson’s stem cell 
derivation: “First, let me first address Dr. Thomson’s work in which cells were derived 
from embryos created (act) by IVF (agency) but not used for infertility treatment 
(purpose) [emphasis added]” (Stem Cell Research, Part 1, 1999, p. 10). 
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At the point of fertilization, the ex utero embryo is defined in a way similar to the 
in utero embryo. The merger of the egg and sperm supply familial definition. For 
instance, stem cell research opponent Lucinda Borden notes that the Zanes, the genetic 
parents of her adopted embryos, conceived 10 embryos. The intended result of infertility 
treatment, birth, supplies the directional definition. However, of course, IVF Process Acts 
indicate a context that is not a part of the experience of the in utero embryo. The 
infertility clinic is the variant context, but even this context supports the familial and 
directional definitions just noted. Congresswoman Carolyn Maloney describes both the 
directional definition of the embryos in that babies have been born and the scene of 
infertility clinics, which she refers to as “fertility clinics:” 
The embryos in question are created (act) in fertility clinics (scene) to help the 
many couples who are having difficulty conceiving a baby (purpose). Because of 
the advances of science, over the last twenty years, nearly 100,000 babies have 
been born (act) in the United States (scene) with the help of assisted reproductive 
technologies, like IVF (agency). [emphasis added] (Opportunities and 
Advancements in Stem Cell Research, 2001, p. 31) 
 
The context of the infertility clinic, confirmed by the scene/act ratio of fertility 
clinic/embryo creation, presents a major linguistic problem for the opponents. The 
problem is not just that the embryo is in an ex utero scene. The problem for the 
opponents, which will become clearer in the research and treatment acts, is that the scene 
of the infertility clinic is a technological scene. Burke (1969) comments on the linguistic 
problem such a scene poses: “ . . . philosophies that would today label themselves 
‘naturalistic’ favor terms taken from the wholly artificial and unnatural realm of 
technological invention and laboratory method” (p. 120). In Opportunities and 
Advancements in Stem Cell Research (2001), supporter and Congressman Henry 
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Waxman positions the debate as one that is about technology when he says, “The stem 
cell debate is fundamentally about IVF and what follows from it” (p. 21). This statement 
provides a technological circumference through which to view the debate. The linguistic 
conundrum is that the language of IVF technology and the infertility treatment it is used 
for introduces the language of production in the process of reproduction so that what is 
encompassed in the normal process of reproduction—conception, gestation, and birth—is 
viewed as natural and obviously dependent on the technological and evokes a sense of the 
mechanized or even the industrial. Within this technological circumference, professor of 
biology Dr. Richard Hynes can say that embryos are “generated” for infertility treatment 
(Stem Cell Research, Part 3, 2000, p. 86). Also, within the technological circumference, 
opponent Lucinda Borden can say that embryos were not “transferred” to a genetic 
mother’s uterus (Opportunities and Advancements in Stem Cell Research, 2001, p. 53). 
So this technological language, emphasized by the scene/act ratio, reminds us that the 
kind of conception being discussed is in some ways different from the conception that is 
completely possible by the physical union of a man and a woman. Opponents’ language 
in the post-infertility treatment acts indicates an attempt to overcome this technological 
language. 
In addition to framing the embryo as a technological construct, the scene/act ratio 
of the infertility clinic/embryo creation also frames the ex utero embryo as a medical 
construct. Other ratios do likewise. Many supporters of the research comment on the 
embryos that are left over after infertility treatment, describing them as being “in excess 
of clinical need” (Stem Cell Research, Part 1, 1998, p. 16; Stem Cell Research, Part 3, 
2000, p. 56). The embryos are defined as a medical entity by their clinical purpose and in 
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a technological/medical circumference for a purpose/scene ratio. This depiction certainly 
depends on context and the conditions of familial origin. No embryo conceived in utero 
is defined as clinical. Most of the references are to ex utero embryos, but the few 
references to in utero embryos refer to them variously as embryos, kids, children, fetuses, 
and babies. 
Finally, the opponents seem to countermand the thrust of their arguments by 
referring to the “IVF industry”/embryo creation (scene/act) ratio, thereby making the 
embryo also an industrial construct by association (Opportunities and Advancements in 
Stem Cell Research, 2001, p. 74). Here, I return to my observation that the IVF Process 
Acts suggest that production is necessary for reproduction. Burke (1969) distinguishes 
between production and reproduction in describing the difference between natural and 
industrial powers, stating, “The forces of reproduction proceed by growth and decay, the 
forces of production proceed by the acceleration and deceleration of motion” (p. 121). In 
attempting to achieve reproduction by IVF, one cannot avoid the inherent motion of the 
production process. Burke describes motion as being antithetical to acts, “what the 
behavioralists would call a response to a stimulus” (p. xx). For Burke, a feature of the 
technological scene is technological motion. At the outset of this chapter, I mentioned 
first impressions. Specifically, my first impression was that the ex utero embryo is 
created by acts of the clinic staff agents. However, my realization that the infertility clinic 
is a technological scene has led me to the conclusion that the infertility clinic has the 
characteristics inherent to technological scenes, namely motion. Here, I equate scientific 
protocol with motion. The scientific protocol could otherwise be described as a 
“procedure” as described by Thomas Okarma, the president of the company that funded 
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the initial isolation of human embryonic stem cells (Stem Cell Research, Part 1, 1998, p. 
51). I postulate that the motion of the infertility treatment process is similar to the passive 
endeavor of the assembly line. Does not the IVF process suggest the motion of an 
assembly line as embryos are generated according to a protocol in an industry? Within 
this line of thought, clinic staff members are not agents at all. They are simply 
constituents of a technological scene. Ultimately, the categorization of the infertility 
clinic as a technological scene complicates the contextual and directional definitions of 
the embryo as members of a family, the definitions that opponents of the research hope to 
convey in Post-Infertility Treatment Acts. 
Post-infertility treatment acts. The literature review refers to the role of ambiguity 
in Burke’s grammar. According to Burke, ambiguity is necessary for transformation to 
occur. The variety of topics in the period after infertility treatment makes the definition of 
the embryo indeterminate when observing all of the terms together. The ambiguity 
highlights the definitional rupture—to use Schiappa’s terms—regarding the term embryo 
and how to define the embryo outside of the uterus. In the post-infertility period, the 
embryo is not just outside the uterus, but it is also in frozen storage. To navigate the 
embryo away from the storage context—to transform it by definition—witnesses use 
directional definition to put the embryo in a new context. 
In IVF Process Acts, embryos were intended for a specific woman’s uterus 
(context – confirmed by agent/act ratio of family/embryo creation and purpose/act ratio 
of reproduction/embryo creation). After infertility treatment, with the embryo being 
frozen in storage, the witnesses expend rhetorical efforts to direct the embryo to a new 
location, a new context. For opponents, the new location is a uterus (context – confirmed 
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by agent/act ratio of any woman/can carry any embryo). Alternatively, supporter 
Congressman Elijah Cummings suggests that the embryo be put into “the hands of 
researchers” (context – confirmed by act/purpose ratio of donation/research) 
(Opportunities and Advancements in Stem Cell Research, 2001, p.9). 
For opponents of the research, the language of embryo adoption both shows 
where the embryo is going (i.e., to a family) and that a new womb is the new context for 
the embryo. Although embryo adoption shares the same quality of family and several 
other pentadic elements (e.g., pregnancy scene, children scene, IVF clinic agent, benefit 
to families purpose), adoption requires a different context (a different womb), supported 
by a different family (agent) from the one initially intended.  
Opponents’ contextual definition of the embryo in the post-infertility treatment 
period also implements familial definition but cuts off the familial tie to define by 
context. Genetic parents enroll (act) their embryos in an adoption program (scene), which 
confirms familial definition. An adoption agency (scene) preserves the familial definition 
of the embryo until the genetic parents sign documents to relinquish parental rights (acts). 
The purpose of this act is to situate the embryo in the new family with inheritance rights 
to accompany the context of the new family. To maintain the definition of the embryo as 
something that is intended for the uterus (context) and for birth, this transformation of the 
embryo from an entity frozen in storage to one that ultimately is born and is part of a 
family requires a balance between the initial context of the embryo and the new one.  
As noted in the Results chapter, for the most part, the ratios of the opponents in 
this period restrict activity to family. However, in opponents’ attempts to maintain the 
natural definition of the embryo as a resident of the uterus, opponents of the research 
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nonetheless use terms of the technological scene of the IVF clinic. Embryos are shipped, 
in nitrogen canisters no less. As in the IVF Process Acts, they are transferred to a 
woman’s uterus. Even after transfer, the pregnancy experience is discussed partially in 
terms of the technological scene of the clinic – i.e., HcG hormone levels confirm 
pregnancy, and an ultrasound is performed to monitor the viability of the embryo. 
However, these last mentioned terms of the technological scene are common to the 
modern pregnancy experience, whether initiated by IVF technology or not. Although 
opponents use the language of pregnancy, adoption, and family, their rhetoric is not fully 
extricated of the language of the technical/medical/industrial scene. Conversely, 
supporters’ language use in the post-infertility treatment acts is consistently reflective of 
the technical/medical scene, whereas the industrial scene is set aside until Research Acts.
 As reported in the Results chapter, supporters use the donor/research 
(agent/purpose), donate/research (act/purpose), and scientist/obtain (agent/act) ratios to 
convey that the embryo goes to the context of the research lab. This directional definition 
transforms the embryo into something that it has never been in its journey from the 
infertility clinic, research material. The following excerpt from Congresswoman’s 
Carolyn Maloney’s testimony explains the options parents have after infertility treatment 
using IVF:  
For those parents who have completed their families using procedures like IVF, 
they have a choice: They make [sic] keep their excess embryos in a frozen state 
for a time or they may donate them to other infertile couples. But there are also 
embryos that are in excess of clinical need. Instead of discarding them, couples 
may donate them for research. (Opportunities and Advancements in Stem Cell 
Research, 2001, p. 31) 
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As research material, the embryo is an agency for the act of research. As an 
agency, the embryo represents Burke’s philosophy of pragmatism. Commenting on the 
role of agency and pragmatism in science, Burke (1969) says that “modern science is par 
excellence an accumulation of new agencies (means, instruments, methods)” (p. 275). 
The new agency of the embryo is made possible by the transformative power of 
language. The parents in IVF Process Acts may be donors in the post-infertility period. 
Even when witnesses say that parents may donate the embryo, the word donor can be 
used by inference. It is this agent who invites the redefinition of the embryo as research 
material, agreeing by informed consent that the embryo may be used for research and 
allowing scientists to obtain the embryo. The act of the donor in donating the embryo for 
the purpose of research is the turning point that indicates that the embryo will go in a 
direction other than implantation in a uterus. Supporters’ ratios of this period confirm that 
the embryo will remain in the technological scene once it is subject to research acts. 
However, the ratios of the Research Acts do the work of introducing a new medical scene 
and new industrial scene. 
Research. The donation of the embryo in the post-infertility treatment period is 
the mechanism that makes the embryo research material. However, supporters of the 
research also benefit from two influential scenes that define the embryo as research 
material: recommendations of the 1994 NIH Human Embryo Research Panel (HERP) and 
guidelines for embryonic stem cell research proposed by the NIH in 2000. Several 
witnesses mention the HERP scene that recommended that the federal government fund 
embryo research. Although his research was not federally funded, Dr. Thomson (the first 
to derive human embryonic stem cells) used the HERP guidelines to maintain scientific 
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ethical standards in conducting his research on isolating human embryonic stem cells 
according to scientific ethical standards. The embryo had been defined as research 
material by the HERP guidelines, but in 1998 and afterward, supporters of federally 
funding the type of research made possible by Dr. Thomson’s innovation had to figure 
out how to define the embryo in the context of the Dickey-Wicker amendment, which 
banned federal funding for research on the embryo, defined as “any organism, not 
protected as a human subject under 45 CFR 46 . . . that is derived by fertilization, 
parthenogenesis, cloning, or any other means from one or more human gametes or human 
diploid cells” (Balanced Budget Downpayment Act, 1996). 
The NIH Guidelines of 2000 (scene) represented the legal distinction that whereas 
an embryo was an organism, an embryonic stem cell was a non-organism. In response to 
the legal distinction, Senator Arlen Specter makes a comment about definition, 
suggesting its relevance in the debate: “The definition of ‘organisms’ and ‘stem cells’ and 
the entire medical lexicon is extraordinarily complicated” (Stem Cell Research, part 1, 
1999, p. 117). The legal opinion made the point that what was being used as research 
material under the auspices of federal funding was not an embryo and it was not an 
organism. The argument had changed. With the embryo being put outside of the federal 
funding context, by the change in the scene/act ratio (location of derivation/derivation), 
the embryo’s definition became a non-issue as far as the NIH was concerned. Its new 
definitional focus was strictly on the stem cell. The embryo was incompatible with the 
scene/act ratio of federal funding/stem cell derivation, so the act of derivation was moved 
to another scene, signifying that context was, indeed, important to the definition of the 
embryo. The embryo still might have been research material but such a definition had no 
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relevance within the context of federally funded research facilities. The impact of the 
change in scene/act ratio was so rhetorically powerful that witnesses who supported the 
research then stopped calling for the Dickey-Wicker amendment to be overturned so that 
federal funds could be used for embryo research. Instead, they placed their arguments 
within the context of the NIH Guidelines (2000)/embryonic stem cell research 
(scene/act). This focus on the actual location of stem cell derivation is not an issue in 
privately funded labs that use embryos. For instance, whereas the NIH Guidelines (2000) 
would require the involvement of 2 labs, one for stem cell derivation and one for stem 
cell research, Dr. Thomson used one lab. So again, context matters—the definition of the 
embryo as research material depends on its context, whether derivation acts take place in 
a federally funded lab or a privately funded one.  
In defining the embryonic stem cell instead of the embryo to overcome their 
definition problem, the supporters use the rhetorical technique of division, described by 
Fahnestock (1999) as a way of “finding the line of argument based on partitioning a 
subject in a useful way, usually to serve an argument from definition” (p. 91). The stem 
cell is defined contextually as what it is not, an organism. The choice of defining the stem 
cell instead of the embryo has the effect of partitioning or dividing the scene/act ratio of 
federally funded lab/stem cell derivation. Nevertheless, by stating where the stem cells 
can be derived, the embryo is being defined contextually as well. Division of the embryo 
would have happened anyway. After all, the disruption of the embryo’s boundaries is 
implicit in human embryonic stem cell research. However, the division of the cell at the 
point of scene demarcation is rhetorical. 
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When the NIH Guidelines (2000) say that stem cells must be derived from 
embryos in labs that are not federally funded and, thus that the embryo should be kept out 
of the federally funded lab, they are conveying the message that, substantially, the 
embryo is not research material, at least not federally funded research material. Here, I 
am using substantially as Burke (1969) uses it: 
. . . the word ‘substance,’ used to designate what a thing is, derives from a word 
designating something that a thing is not. That is, though used to designate 
something within the thing, intrinsic to it, the word etymologically refers to 
something outside the thing, extrinsic to it. Or otherwise put: the word in its 
etymological origins would refer to an attribute of the thing’s context, since that 
which supports or underlies a thing would be part of a thing’s context. And a 
thing’s context, being outside or beyond the thing, would be something that the 
thing is not. (p. 23)  
 
Burke (1969) continues, stating that “The ambiguity of substance affords, as one 
might expect, a major resource of rhetoric” (p. 51). With the division of the scene/act 
(federally funded lab/stem cell derivation) ratio, supporters of the research do not have to 
make the argument that the embryo should be used for research, thereby challenging the 
standing Dickey-Wicker amendment. They only need to establish the embryo is not 
research material, substantially (i.e., contextually). By having the derivation process 
completed in a lab that is not federally funded, nothing of the context of the embryo will 
be related to federal funds.  
The NIH Guidelines’ (2000) stipulation that federal funds would only be used for 
research on the embryonic stem cells and not on embryos essentially takes opponents out 
of the debate. Whereas opponents are debating the proper place of the embryo, by 
depending on the scene of NIH Guidelines, the supporters are debating the proper place 
of the embryonic stem cell. Interestingly, the NIH Guidelines do not ignore that embryos 
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must be used if embryonic stem cell research is to occur. The Guidelines simply 
demarcate the boundaries for which federal funding is applicable.  
The supporters’ reduction of action to motion also quells the debate. According to 
Burke, one way to dissolve drama is to reduce action to motion. In Burkeian terms, Dr. 
Thomson’s (agent) isolation of embryonic stem cells was an act. The data for this study 
show that Dr. Thomson and his colleagues are the most frequently mentioned agents in 
the Research Acts. Subsequent uses of their innovation in a scientific protocol are forms 
of motion. Burke contends that the removal of the agent in the agent/act ratio results in 
motion, and that is what remains in the protocol to derive embryonic stem cells. 
The emphasis on motion and production is further supported by the emphasis of 
some witnesses on the unlimited supply of cells that the embryonic stem cells would 
provide for research and transplant purposes. The representative for the Alliance on 
Aging notes, “The Wisconsin researchers believe these cells have the potential to supply 
unlimited quantities of normal cells of virtually any tissue type” (Stem Cell Research, 
part 1, 1999, p. 77). Also, the transplantable cells are described in supply terms. Senator 
Strom Thurmond demonstrates: “Scientists believe that stem cells could be used to 
produce a supply of healthy cells and tissues that can be used for transplantation” (Stem 
Cell Research, part 2, 1999, p. 20). 
These supplies are portrayed as readily available but without a protocol to prepare 
them for treatment (acts). The goal of the proposed research is to develop a protocol to 
prepare the cells for treatment purposes. In the absence of an actual protocol, witnesses 
invent a skeleton protocol. The skeleton protocol includes differentiation and genetic 
manipulation of cells. For example, Michael West, president of a biotechnology 
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company, makes the following comment about differentiation: “This research has great 
potential to help solve the first problem of tissue availability, but the technologies to 
direct these cells to become various cell types in adequate quantities remains to be 
elucidated” (Stem Cell Research, part 1, 1999, p. 21). Without the specific steps to 
differentiate the embryonic stem cells, witnesses can use the term differentiate as a 
placeholder for the step that is known to be necessary. Likewise, some witnesses 
comment on the challenge of overcoming potential immune rejection in transplant 
recipients. Thomas Okarma comments about embryonic stem cells: “ . . . they have the 
potential to be genetically engineered to prevent their immune rejection by the transplant 
recipient” (Stem Cell Research, part 1, 1999, p. 55). That the embryonic stem cell will be 
able to treat diseases is a strong assumption of supporters. Mary Tyler Moore, 
representing the Juvenile Diabetes Foundation, sums up the entire production process: 
“When scientists are able to specialize these cells to become insulin-producing islet cells, 
cell lines could be developed to produce an unlimited number of insulin-producing cells. 
This would effectively solve the supply problem” (Stem Cell Research, part 3, 2000, p. 
115). 
Moore’s example and others in Research Acts describe a 
technological/medical/industrial scene quite different from that described in IVF Process 
Acts. The Research Acts introduce technical words like specialize and cell lines. Instead 
of being the infertility clinic, the intended medical scene is now the general clinic. In 
addition, the supply being discussed is the supply of cells, not of embryos. The rhetoric of 
the cell emerges in the Research Acts, but it is the cell of technological/medical/industrial 
scene, not the cell of the body. In a significant way, the experience of this cell is similar 
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to the experience of the ex utero embryo. The ex utero embryo has to be produced in a 
technological sense in order to be reproduced in the natural, bodily sense. The cell under 
discussion is reproduced in a laboratory in order to be introduced into the body as 
treatment. Also, similar to the opponents, the supporters of embryonic stem cell research 
argue for the proper direction of these cells. For them, the patient’s body is akin to the 
womb that would receive an embryo that has been fertilized in an infertility clinic. 
Treatment. In Research Acts, the act/purpose ratio of research (all acts)/treatment 
predicts the direction for the embryonic stem cell, that it will be used as therapy. 
Supporters portray treatment as inevitable. For instance, Congressman Elijah Cummings 
quotes William Safire in an editorial published in The New York Times: “[t]he stem cell 
genie is out of the research bottle. . . . Whether driven by private funds here or by the 
investment of money by foreign governments, embryonic cells will be used to achieve 
breakthroughs to cures” (Opportunities and Advancements in Stem Cell Research, 2001, 
p. 10). 
Safire uses the language of motion, particularly his comment that advances in 
stem cell research will be driven by someone, whether in the U.S. or abroad. In addition, 
some witnesses seem to depend on the testimony of scientists to validate the reality of 
treatments. Senator Dianne Feinstein’s testimony below is not uncommon in referring to 
scientists’ belief in the eventual results of embryonic stem cell research: 
As NIH Director Dr. Harold Varmus testified before this subcommittee on 
December 2, 1998, by better understanding cell development, “research on stem 
cells could help us understand the complex events that occur during human 
development.” He also explained quite eloquently how many diseases and 
disorders are the result of disruption of cellular function or destruction of tissues 
of the body and that some day in the future, stem cells could be a renewable 
source of replacement cells to treat a broad range of diseases. He said, for 
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example that the transplant of healthy heart muscle cells could provide new hope 
for heart attack victims. (Stem Cell Research, part 2, 1999, p. 23) 
 
After a long process from infertility clinic though research, the embryo has been 
reduced to its cells to be delivered as treatments for a number of conditions. The embryo 
is no more, yet the technical/medical/industrial scene remains, although one different 
from that of the infertility clinic. The embryonic stem cells that may be transplanted are a 
technology, a medical tool, and an industrial product—an agency multiplied in the 
laboratory and fashioned, ideally, for individual patients. They mark the end of an 
assembly process that has shed the boundaries of the embryo and taken on the specialized 
characteristics required by a medical consumer. 
As proposed, cells and tissues developed from embryonic stem cells are a 
commodity in a way that transplanted organs are not. For instance, the U.S. Patent and 
Trademark Office has no involvement in patenting someone’s donated bodily organs. 
However, the subject of patents comes up several times in the debate about embryonic 
stem cells. The president of the Biotechnology Industry Association comments on the 
importance of patent protection to embryonic stem cell advances: “For industry to 
continue to fund this research and for this research to be developed into products at the 
bedside for patients, patent protection must be available” (Stem Cell Research, part 1, 
1999, p. 104). As mentioned earlier in this dissertation, regarding embryo-based 
treatments, Senator Tom Harkin testifies, “I want to make it clear that I do not believe 
that research should be done solely for research's sake. We must continue to ensure that 
incentives are in place for promising inventions to get to market” (Stem Cell Research, 
part 1, 1999, p. 93). Essentially, the technological/medical/industrial scene of infertility 
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treatment clinics has begotten another technological/medical/industrial scene in the use of 
embryo-based or embryonic stem cell-based treatments to treat various conditions.  
NIH, the God-term 
Besides the witnesses’ wielding of definitional acumen in the framing of the 
embryo, how has one technological/medical/industrial scene morphed into another? In 
the corpus, one pentadic element serves as an organizing mechanism to bring this 
transition to bear. The pentadic element that stands out from the others is the scene of 
NIH Guidelines (2000). The breadth of this scene extends from IVF Process Acts to 
Treatment Acts. In IVF Process Acts, the NIH Guidelines position the embryo for use in 
types of acts unavailable in the blastocyst/fertilized egg/embryo creation pentad. But in 
those other acts, there is always a familial link to the IVF Process pentads. In the scene of 
NIH Guidelines, familial definition requires more than the condition of the 
blastocyst/fertilized egg/embryo creation act, the merger of the egg and sperm. Familial 
definition in the NIH scene requires purpose, too. For the Guidelines state that embryos 
used to derive stem cells that are used in federally funded research must have been 
created for the purpose of infertility treatment. Only stem cells from this type of family 
line (familial definition) are eligible for the context of federally funded research. Also, 
the NIH Guidelines scene connects the embryo to two future dramatic settings: research 
and treatment. Not only does the scene/purpose ratio (NIH Guidelines/infertility 
treatment) provide contextual definition, in its gesture toward a future pentad, it also 
follows Burke’s concept for directional definition. At the end of IVF Process Acts, the 
question still remains about how to direct the embryo from the infertility treatment 
context to another context because after treatment, the embryos are frozen. The rhetorical 
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activity in the post-infertility treatment period helps to explain direction of the embryo to 
another context.  
Once they are proposed, the Guidelines (2000) are a mainstay of supporters’ 
scenes. In being so, the NIH Guidelines serve as the supporters’ god-term. Babin and 
Harrison (1999) describe Burke’s coining of this label: 
According to Burke, language use tends to culminate in an ‘ultimate’ or ‘god-
term. In Burke’s philosophy, god-terms stand in the place of “God”; words and 
the concepts they invoke guide a community and provide its ultimate motives; 
they also uphold and stabilize ideology. God-terms influence all action, thought, 
and communication within a community. (p. 183) 
 
The whole argument for federally funding embryonic stem cell research emanates 
from this term. It is the ultimate background for supporters. Speaking for the American 
Society for Cell Biology, Richard Hynes says of the NIH Guidelines (2000): 
. . . we believe it would be immoral not to pursue embryonic stem cell research, 
within the appropriate regulatory oversight mandated by the NIH Guidelines, 
because this research has enormous potential to save human lives and to mitigate 
human suffering. The embryos in question would be obtained from IVF clinics 
only from those in excess of clinical need. (Stem Cell Research, part 3, 2000, p. 
86) 
 
At once, Hynes connects IVF Process Acts to Treatment Acts by using the NIH 
Guidelines. Supporters commonly apply the NIH Guidelines in this way. Opponents of 
the research have no such god-term, a term that conveys their entire message. 
The development of the NIH Guidelines (2000) in concert with the legal opinion 
of the General Counsel of the Department of Health and Human Services makes them 
impenetrable. Also, opponents do not seem to fully realize the definitional flexibility 
inherent to science and the law. According to Schiappa (2006), “legislative definitions are 
stipulative definitions as to what particular words mean within the context of a given 
 95
law” (p. 52). In other words, legal definitions are not necessarily the same definitions that 
exist in the everyday lexicon. As for the definitional flexibility of science, over hundreds 
of years, science has developed an intricate classification system that is used to define 
objects of scientific research and interest. In changing the research question to one that 
focuses on the cell, scientists benefit from the widely held view that cells are the basic 
building blocks of life but that they do not comprise all of life itself.  
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Chapter 6: Conclusions 
My initial concern in this study was to identify patterns of language use in the 
debate that would explain how the embryo came to be a treatment. During the analysis of 
the corpus, I realized that I needed to ask a more preliminary question about how the 
witnesses defined the embryo, whether for treatment or any other reason. The results of 
this study have shown that the human embryo is more than the earliest form of human 
life. I found that, at least in the debate analyzed in the dissertation, the embryo is a 
concept that denotes multiple meanings, depending on the person who is discussing the 
embryo. Also, I found that the clear argumentative strategies used in the embryonic stem 
cell debate demonstrate that the communication of modern science—even 
communication about the nascent form of human life—exceeds positivist notions of 
concrete scientific proofs. The question of how an entity is proven to be a particular 
something for a particular purpose was the central exploration of this dissertation. In the 
words of their prepared statements, very few witnesses offered what they could see in 
microscopes and Petri dishes as proof of the embryo’s fitness or lack thereof for the 
development of treatments. Instead, I found that witnesses turned to the persuasive act of 
definition. 
Witness testimony demonstrated the flexibility of definition. All parties entered 
the debate about embryonic stem cell research with an attempt to define the embryo 
according to their interests, but during the debate supporters of the research were able to 
reposition pentadic elements to focus on the definition of the embryonic stem cell. 
Clearly, the inner workings of the federal government in the General Counsel’s statement 
and the NIH director’s precise focus on the cell instead of the embryo led to the 
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deflection of the embryo question in lieu of the question of whether research could be 
done on the embryonic stem cell.  
The present study also shows that the making of science extends from the science 
lab and includes stakeholders other than scientists. Although the discourse of the 
embryonic stem cell debate does not reflect Leshner’s (2005) call for scientists and the 
general public to work together to set the agenda of science, it does suggest that scientists 
do collaborate with nonscientists in their work. For instance, patient advocacy groups, 
individual patients, and lawmakers supported the request that federal funds be used for 
embryonic stem cell research. Again, the General Counsel weighed in as well. These 
contributions demonstrate that scientific expertise alone is not enough to conduct publicly 
funded science, and several witnesses make the point that publicly funded science is a 
major contributor to innovation in the U.S. Supporters of the research, even privately 
funded ones, argue that allowing publicly funded scientists to conduct embryonic stem 
cell research is vital to the country’s ability to make productive advances that may lead to 
treatments. Without the collective voices that support public science, some scientific 
advances will not be made. So the definitions that are used to execute federally funded 
research are pivotal to this certain type of science as a whole. Furthermore, given the 
existing legislation prohibiting research on human embryos, supporters’ rhetorical 
acumen in defining their research material is the lynchpin of future research. As for the 
opponents, their ingenuity in creating new contextual, familial, and directional definitions 
for the embryo were not enough to compete with the NIH god-term.  
When President Bush issued his directive on embryonic stem cell research, he did 
not view the NIH Guidelines (2000) as a god-term. He challenged the Guidelines and 
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narrowed the circumference for what would qualify as research material from any 
embryonic stem cell to only the stem cells that had already been isolated as of the date of 
his directive. This decision, however, did not address the definition of the embryo. Like 
the supporters of the NIH Guidelines, it only addressed the issue of what to do with the 
embryonic stem cells. Regarding action on the embryo, President Bush issued a kind of 
moratorium on embryo research, as his predecessors President Reagan and the first 
President Bush had done. The decision did not confront the definitional rupture regarding 
the embryo. Nonetheless, we know that the opponents’ arguments for the definition of the 
embryo as a resident of the womb and nascent child were ineffectual, not enough to 
change the course of the debate across political lines since President Obama issued a 
directive in 2009 that would allow embryonic stem cell research beyond those stem cell 
lines available before President Bush’s announcement. Unsurprisingly, these two 
presidential directives show that public science is political. Still, the witnesses used the 
definitional resources that were available to them at the time, regardless of which 
political party was in power. 
Ultimately though, the debate showed that as much as the cells in a Petri dish are 
physically manipulable, the meaning of human forms and constituent parts is rhetorically 
manipulable, at least rhetorically. The witnesses described do not mention Burke’s 
pentadic terms, but some of them ably use the concepts that the terms represent. For 
instance, some witnesses promulgate the NIH Guidelines (2000), which positioned the 
place (scene) of stem cell derivation (act) in a non-federally funded lab instead of a 
federally funded one. Also, by placing the embryo within the accoutrements of traditional 
adoption, some witnesses construct a meaning of the embryos as children. My use of 
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Burke’s pentad was pivotal in teasing out the rhetorical components that fostered these 
differing views. 
Multipentadic Analysis and Definition 
The pentad offered a tremendous data management apparatus. Although I had a 
voluminous amount of data, I was able to maintain confidence in my points of 
comparison because of the pentad’s built-in requirement for relationship analysis in the 
ratios. Also, the pentadic elements provided a firm scaffolding on which to build the 
unfolding drama and a consistent way to connect pentads to each other so that I could 
observe patterns across the path of the embryo from its creation to its end.  
Burke’s pentad is a tool that helps analysts to identify what people are doing and 
why, in a given situation. One benefit of analyzing a corpus that covers several pentadic 
sets is that a fully developed picture of the what and why may emerge. Multipentadic 
analysis was useful for studying this corpus because of the dramas within dramas that 
appeared to run throughout the corpus. Even if I had used embryonic stem cell research 
as my starting point in a single pentadic analysis, I would have soon discovered that I 
would have had to trace back to the infertility treatment clinic to find the source of the 
embryo. I would have then found that all roads do not go back to embryonic stem cell 
research. I would have found some stories of embryo adoption instead. Like Rountree, in 
his study of judicial discourse, I identified pentadic sets that depended on other pentadic 
sets. I found that in the context of the public discourse I studied, events build upon each 
other, whether these events in themselves are related or not. For instance, the NIH 
Guidelines (2000) portray infertility treatment as being related to stem cell research 
simply by stipulating that the purpose of embryo creation must be infertility treatment. 
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Infertility treatment is thereby made part of the context of embryonic stem cell research, 
and one cannot refer to embryonic stem cell research without also referring to infertility 
treatment. This example is illustrative of the value of multipentadic analysis in shedding 
light on aspects of a drama that otherwise would be masked in a single pentadic analysis. 
Analyzing multiple pentads in the drama of the embryonic stem cell research 
debate has allowed me to see how the witnesses, particularly the supporters, use two 
types of ratios: positional ratios used to locate the immediate context and connective 
ratios used to provide cohesion between pentadic sets and whole arguments. The 
purpose/scene ratio of infertility treatment/infertility clinic functions as a positional ratio. 
It suggests where the embryo is in whatever process being described by the witnesses. 
The ratios that provided directional definition would be deemed connective ratios. For the 
supporters, one important component of cohesion is the set of NIH Guidelines (2000), the 
god-term discussed previously. This god-term actually has the potential to frame all of 
embryo research, not just federally funded research. Although his work was privately 
funded, Dr. Thomson used the NIH HERP guidelines for isolating human embryonic 
stem cells the first time. Perhaps, the newer NIH Guidelines (2000) may be similarly used 
by other privately funded researchers. For although the guidelines establish the scene for 
federally funded research, they also have the potential to set the scene for privately 
funded research. Additionally, although the guidelines serve a practical function in 
providing a framework for stem cell research, the guidelines also serve a rhetorical 
function in substantiating the work.  
Using Burke’s approaches to definition worked well with multipentadic analysis 
because I was able to mentally shuttle between pentadic sets to view the relationships 
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between them. Familial and directional definitions were especially helpful in this regard. 
Ultimately, in order to arrive at definitions held in a debate, analysis of more than one 
pentad was necessary in my study. 
Limitations 
Like all studies, the present one has its limitations. One limitation to the study is 
that it does not analyze the acts and pentads that were criticized by witnesses as 
undesirable acts for the embryo. For instance, the study did not examine opponents’ 
direct arguments against embryonic stem cell research. Arguing against another argument 
is a strategy in itself, but analysis of this strategy was outside the aims of the present 
study. Also, of course, the study is limited by its dependence on Kenneth Burke’s 
dramatistic pentad as an analysis tool, but any rubric would be accompanied by 
limitations, although perhaps different ones. Use of another analysis tool would 
undoubtedly yield alternative results, but those results would be no more valid than the 
ones contained in this study.  
Another limitation of this study can be attributed to the corpus itself. Because of 
the selectivity of the process to invite hearing participants, relevant voices will 
undoubtedly be omitted from the debate. In particular, no donors (or genetic parents) 
contributed to the hearings. Because I was not privy to the invitation lists for the hearing, 
I cannot say whether any donors (or genetic parents) were invited to testify. However, 
their absence from the debate might suggest that hearing chairmen already viewed the 
embryos as being without familial definition. Therefore, they might have deemed the 
course for the embryos available for debate. 
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Suggestions for Further Study and Pedagogical Application 
Although Burke provides extensive commentary on the broader meanings of his 
pentadic elements (i.e., the philosophies that they suggest), he emphasizes the function of 
the pentad as a grammar. Essentially, the terms label the parts of a drama, giving an 
account of the motives or sources of why people do what they do. The pentads provide 
images of the operative dramas, and the images may be used for more extensive analysis 
in a number of directions. Below, I describe a few of them.  
Supporters said that embryonic stem cells proliferate to such a degree that they 
will most likely be useful in medicine. This unfettered proliferation doesn’t occur in an 
IVF clinic, in a womb, or even inside the embryo itself. This proliferation is a 
phenomenon of the research lab. The redefinition of the embryo from a medical treatment 
for infertility to a medical treatment for all conditions required that all boundaries be 
stripped so that the research material would be conducive to the environment or scene of 
a research lab. Future analysis might include a study of the circumference of the embryo, 
the shifting boundaries as dependent on the stakeholder. What are the indicators of 
boundaries on the level of the embryo? What boundaries do we place on human material, 
and what do those boundaries represent philosophically and sociologically? 
One might use the findings of the present study to complete a rhetorical analysis 
that examines the word choices in each pentadic set and what such choices say about 
concepts such as personhood or biotechnology—all concepts that emerged in the pentadic 
study described in this dissertation.  
Studies of other public debates should be conducted to observe whether similar 
patterns of argument emerge. One question that remains after this study is whether the 
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patterns observed are unique to the current debate or whether similarities would appear 
among other public debates. In particular, the argumentative use of definition in public 
discourse should be analyzed. Also, from this study emerged a question of the 
development of the embryo and its derivatives as products. The development of 
treatments from embryonic stem cells will greatly increase the market for embryo 
products, so a study of the rhetoric of embryo commercialization might be quite 
compelling. 
Finally, the findings of the dissertation demonstrate that a fully engaged citizenry 
should be apprised of the strategies of argument. In addition, today’s increasingly 
technological scene calls for a citizenry who can comprehend the language and practices 
of science well enough to participate in debates of national scientific interest. Teachers of 
writing would do well to expose students to the wide array of issues presented by 
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IVF Process by Witness and Position   
  Position 
Witness Type Supporter Opponent 
Elected official 3 0 
Scientist 3 0 
Patient 0 0 
Nuclear family 0 2 
Patient advocacy group 1 0 
Scientific professional organization 1 0 
Religious organization 0 1 
Other organization 0 1 
Scientific company 2 0 
 
Table A2  
Types of IVF Acts 
IVF Act Number of Documents Coded 
Blastocyst created 1 
Embryos created 12 
Fertilized eggs created 2 
Implantation  2 
 
Table A3 
Post-Infertility Treatment by Witness Type and Position 
  Position 
Witness Type Supporter Opponent 
Elected official 4 3 
Scientist 4 1 
Patient 2 0 
Nuclear family 0 2 
Patient advocacy group 1 0 
Scientific professional organization 3 0 
Religious organization 0 1 
Other organization 0 2 




Types of Post-Infertility Treatment Acts 
Act Number of Documents Coded 
Adoption  9 
Birth  1 
Care for embryo  1 
Donation  10 
Embryos discarded  5 
Embryos frozen  7 
Embryos not implanted  6 
Legal protection  3 
No chance of becoming human life 3 
Obtain embryos  4 
Parenting act  1 
Post IVF treatment  1 
Pregnancy  2 
Prevent massacre  1 
Speak for embryo  1 
 
Table A5 
Research by Witness Type and Position   
  Position 
Witness Type Supporter Opponent 
Elected official 8 0 
Scientist 8 0 
Patient 2 0 
Nuclear family 0 0 
Patient advocacy group 3 0 
Scientific professional organization 4 0 
Religious organization 0 0 
Other organization 0 0 










Types of Research Acts   
Act Number of Documents Coded 
Bank cell lines  2 
Cell replate  1 
Cells dissociated  1 
Cells harvested  1 
Cells purified  1 
Create new source of cells  3 
Culture  4 
Derivation  14 
Differentiation  11 
Discovery of hES cells  3 
Establish new cell lines  4 
Genetically manipulate cells  3 
Grow cells  6 
Immortalize cells  3 
Isolation  8 
Obtain cells from different lab  1 
Prepare cells  1 
Research  26 
Store cells  1 
 
 
 Table A7 
Treatment by Witness Type and Position  
  Position 
Witness Type Supporter Opponent 
Elected official 4 0 
Scientist 7 0 
Patient 1 0 
Nuclear family 0 0 
Patient advocacy group 2 0 
Scientific professional organization 3 0 
Religious organization 0 0 
Other organization 0 0 
Scientific company 2 0 
Table A8 
Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Agency     
Adoption  0 2 0 0 
Broader ban  0 1 0 0 
Cell lines  0 0 6 2 
Cells  0 0 3 0 
Characteristics of cells  0 0 1 1 
Differentiated cells  0 0 1 2 
Embryonic cells  0 1 2 1 
Embryonic tissues  0 0 1 0 
Embryos  0 3 12 0 
Ethical conduct  0 1 3 0 
FedEx  0 1 0 0 
Fertilized eggs  0 0 1 0 
Further inquiry  0 0 0 1 
Gene products  0 0 0 1 
Genes that regulate development of stem cells  0 0 1 0 
Growing cells  0 0 1 0 
Highest scientific standards 0 0 1 0 
Informed consent  0 8 0 0 
Inner cell mass cells  0 0 1 0 
IVF  4 6 1 1 
Lab technique  0 0 4 0 
Legal conduct  0 0 1 0 
Licenses  0 0 1 0 
Overview and regulation  0 0 1 0 
Pregnancy  0 2 0 0 
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(Continued) Table A8 
Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Agency     
Remains to be elucidated  0 0 1 0 
Stem cell development  0 0 1 0 
Stem cells  0 0 24 11 
Technology  0 1 1 3 
Thawing  0 0 0 0 
Transplantation of cells  0 0 0 2 
Transplantation of simple tissues  0 0 0 1 
Agent     
Any woman  0 1 0 0 
Congressman Smith  0 1 0 0 
Donors  0 2 0 0 
Embryos  0 2 0 0 
Family  3 12 0 0 
Federal government  0 2 1 0 
Human beings  0 1 0 0 
Industry  0 0 1 1 
IVF clinic  1 8 0 0 
Patent office  0 0 1 0 
Scientist 0 2 19 2 
Purpose     
Adoption agreement  0 1 0 0 
Adoption  0 1 0 0 
Adult stem cells  0 0 1 0 







0 Basic research 
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(Continued) Table A8 
Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Purpose     
Benefit families 5 6 3 0 
Cell potential to supply unlimited cell quantities  0 0 6 1 
Cells are young 0 0 1 0 
Clinical research  0 0 1 0 
Conception  0 1 0 0 
Determine best way to generate useful cells  0 0 1 0 
Ethics  0 1 1 0 
Future use  0 1 0 0 
Hope to families  0 0 1 0 
Human lives  0 0 0 0 
Inheritance rights  0 1 0 0 
IVF   1 2 1 0 
Lab process  0 2 5 1 
Less expense  0 1 0 0 
Life saving  0 0 0 0 
Limitations of adult stem cells  0 0 1 0 
Medical   4 4 26 17 
Name of adoptive family  0 1 0 0 
Not about abortion  0 1 0 0 
Not derivation of ES cell line  1 0 0 0 
Parenting a waiting child  0 1 0 0 
Possible medical benefits  0 0 0 0 
Preserve commercial value  0 0 2 0 
Reduce reliance on human fetal and animal tissue  0 0 0 1 
Research  0 5 13 1 
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Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Purpose     
Science  0 0 0 0 
To give same rights as person  0 0 1 0 
Value embryos  0 1 1 0 
Welcome citizens of the country  0 1 0 0 
Scene     
Adoption   0 4 0 0 
After IVF   0 1 1 0 
Age  0 1 0 1 
Alternative to guidelines  0 0 1 0 
Animal  0 0 0 3 
Availability of hES cells  0 0 1 1 
Belief   0 1 6 2 
Children  0 2 0 0 
Closer scientific examination  0 0 1 0 
Commercial  0 0 3 2 
Complete IVF process  6 9 0 0 
Controversial subject in Washington  0 0 1 0 
Debate   1 1 3 0 
Described discovery of hES cell techniques  0 0 5 1 
Documents  0 1 3 2 
Embryo  0 2 9 0 
ESC qualities   0 0 0 1 
Ethical standards   0 0 4 
14 
0 
1 Ethics  




3 4 0 
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Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Scene     
Excitement  0 0 2 1 
Family  0 4 1 0 
Funding   0 1 14 1 
Future   0 0 4 3 
hES cells defined  1 2 4 1 
Home  0 2 0 0 
Hope   0 0 5 1 
Imagination  0 0 1 0 
Law   0 4 7 0 
Legislation   0 2 2 0 
Medicine   4 10 21 9 
Moral uncertainty  0 1 0 0 
Morality of situation   0 1 3 1 
Nation   0 4 6 1 
NBAC  0 1 3 0 
Not enough data on types of stem cells  0 0 1 0 
Not in excess of clinical need  0 1 0 0 
Number of fertilized eggs   0 1 1 0 
Only animal and transformed human cells available 
in past  0 0 1 0 
Outside womb or uterus  0 2 2 0 
Parts and Phases of embryo   0 0 2 0 
Place   









Qualities of ES cell lines  0 0 1 0 
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Master Pentadic Set         
Pentadic Element IVF Process Post-Infertility Treatment  Research Lab  Treatment  
Scene     
Qualities of stem cells  0 0 1 1 
Quality of life  0 0 0 1 
Religion  0 2 1 0 
Scientist words   0 0 17 3 
Separation between acts  0 2 1 0 
Spirit of humanity   0 0 1 0 
Stages of embryo  1 1 5 1 
State of embryo  0 0 1 0 
State of hES cells  0 0 2 0 
Supporter of funding  0 1 10 2 
The past embryogenesis inaccessible  0 0 1 1 
Time   1 9 19 5 

















Agency         
Adoption  0 0 0 0 
Broader ban  0 0 0 0 
Cell lines  0 0 0 0 
Cells  0 0 0 0 
Characteristics of cells  0 0 0 0 
Differentiated cells  0 0 0 0 
Embryonic cells  0 0 0 0 
Embryonic tissues  0 0 0 0 
Embryos  0 0 0 0 
Ethical conduct  0 0 0 0 
FedEx  0 0 0 0 
Fertilized eggs  0 0 0 0 
Further inquiry  0 0 0 0 
Gene products  0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 
Growing cells  0 0 0 0 
Highest scientific standards 0 0 0 0 
Informed consent  0 0 0 0 
Inner cell mass cells  0 0 0 0 
IVF  0 3 1 0 
Lab technique  0 0 0 0 
Legal conduct  0 0 0 0 
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Agency     
Licenses  0 0 0 0 
Overview and regulation  0 0 0 0 
Pregnancy  0 0 0 0 
Remains to be elucidated  0 0 0 0 
Stem cell development  0 0 0 0 
Stem cells  0 0 0 0 
Technology  0 0 0 0 
Thawing  0 0 0 0 
Transplantation of cells  0 0 0 0 
Transplantation of simple tissues  0 0 0 0 
Agent         
Any woman  0 0 0 0 
Congressman Smith  0 0 0 0 
Donors  0 0 0 0 
Embryos  0 0 0 0 
Family  0 3 0 0 
Federal government  0 0 0 0 
Human beings  0 0 0 0 
Industry  0 0 0 0 
IVF clinic  0 1 0 0 
Patent office  0 0 0 0 
Scientist 0 0 0 0 
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Purpose     
Adoption agreement  0 0 0 0 
Adoption  0 0 0 0 
Adult stem cells  0 0 0 0 
Avoid embryo termination  0 0 0 0 
Basic research 0 0 0 0 
Benefit families 0 4 1 0 
Cell potential to supply unlimited cell quantities  0 0 0 0 
Cells are young 0 0 0 0 
Clinical research  0 0 0 0 
Conception  0 0 0 0 
Determine best way to generate useful cells  0 0 0 0 
Ethics  0 0 0 0 
Future use  0 0 0 0 
Hope to families  0 0 0 0 
Human lives  0 0 0 0 
Inheritance rights  0 0 0 0 
IVF   0 0 1 0 
Lab process  0 0 0 0 
Less expense  0 0 0 0 
Life saving  0 0 0 0 
Limitations of adult stem cells  0 0 0 0 
Medical   0 3 1 0 
Name of adoptive family  0 0 0 0 
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Purpose     
Not about abortion  0 0 0 0 
Not derivation of ES cell line  0 1 0 0 
Parenting a waiting child  0 0 0 0 
Possible medical benefits  0 0 0 0 
Preserve commercial value  0 0 0 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 
Research  0 0 0 0 
Science  0 0 0 0 
To give same rights as person  0 0 0 0 
Value embryos  0 0 0 0 
Welcome citizens of the country  0 0 0 0 
Scene         
Adoption   0 0 0 0 
After IVF   0 0 0 0 
Age  0 0 0 0 
Alternative to guidelines  0 0 0 0 
Animal  0 0 0 0 
Availability of hES cells  0 0 0 0 
Belief   0 0 0 0 
Children  0 0 0 0 
Closer scientific examination  0 0 0 0 
Commercial  0 0 0 0 
Complete IVF process  1 6 0 0 
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Scene     
Controversial subject in Washington  0 0 0 0 
Debate   0 0 1 0 
Described discovery of hES cell techniques  0 0 0 0 
Documents  0 0 0 0 
Embryo  0 0 0 0 
ESC qualities   0 0 0 0 
Ethical standards   0 0 0 0 
Ethics  0 1 0 0 
Excess   0 1 0 0 
Excitement  0 0 0 0 
Family  0 0 0 0 
Funding   0 0 0 0 
Future   0 0 0 0 
hES cells defined  1 0 0 0 
Home  0 0 0 0 
Hope   0 0 0 0 
Imagination  0 0 0 0 
Law   0 0 0 0 
Legislation   0 0 0 0 
Medicine   0 3 1 0 
Moral uncertainty  0 0 0 0 
Morality of situation   0 0 0 0 
Nation   0 0 0 0 
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Scene     
NBAC  0 0 0 0 
Not enough data on types of stem cells  0 0 0 0 
Not in excess of clinical need  0 0 0 0 
Number of fertilized eggs   0 0 0 0 
Only animal and transformed human cells available in past 0 0 0 0 
Outside womb or uterus  0 0 0 0 
Parts and Phases of embryo   0 0 0 0 
Place   0 0 0 0 
Pregnancy   0 0 0 0 
Qualities of ES cell lines  0 0 0 0 
Qualities of stem cells  0 0 0 0 
Quality of life  0 0 0 0 
Religion  0 0 0 0 
Scientist words   0 0 0 0 
Separation between acts  0 0 0 0 
Spirit of humanity   0 0 0 0 
Stages of embryo  1 0 0 0 
State of embryo  0 0 0 0 
State of hES cells  0 0 0 0 
Supporter of funding  0 0 0 0 
The past embryogenesis inaccessible  0 0 0 0 
Time   0 1 0 0 
Types of cells 0 0 0 0 
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Agency         
Adoption  1 0 0 1 
Broader ban  0 0 0 0 
Cell lines  0 0 0 0 
Cells  0 0 0 0 
Characteristics of cells  0 0 0 0 
Differentiated cells  0 0 0 0 
Embryonic cells  0 0 0 0 
Embryonic tissues  0 0 0 0 
Embryos  1 0 0 0 
Ethical conduct  0 0 0 0 
FedEx  1 0 0 0 
Fertilized eggs  0 0 0 0 
Further inquiry  0 0 0 0 
Gene products  0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 
Growing cells  0 0 0 0 
Highest scientific standards 0 0 0 0 
Informed consent  0 0 0 6 
Inner cell mass cells  0 0 0 0 
IVF  3 1 0 1 
Lab technique  0 0 0 0 
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Agency     
Legal conduct  0 0 0 0 
Licenses  0 0 0 0 
Overview and regulation  0 0 0 0 
Pregnancy  2 0 0 0 
Remains to be elucidated  0 0 0 0 
Stem cell development  0 0 0 0 
Stem cells  0 0 0 0 
Technology  0 0 0 0 
Thawing  0 0 0 0 
Transplantation of cells  0 0 0 0 
Transplantation of simple tissues  0 0 0 0 
Agent         
Any woman  1 0 0 0 
Congressman Smith  1 0 0 0 
Donors  0 0 0 2 
Embryos  2 0 0 0 
Family  7 0 1 5 
Federal government  0 0 0 0 
Human beings  1 0 0 0 
Industry  0 0 0 0 
IVF clinic  3 0 0 4 
Patent office  0 0 0 0 
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Post-Infertility Treatment Pentadic Sets: Adoption, Birth, Care for Embryo, Donation 
  








Agent     
Scientist 0 0 0 0 
Purpose         
Adoption agreement  1 0 0 0 
Adoption  1 0 0 0 
Adult stem cells  0 0 0 0 
Avoid embryo termination  0 0 0 0 
Basic research 0 0 0 0 
Benefit families 4 1 0 2 
Cell potential to supply unlimited cell quantities  0 0 0 0 
Cells are young 0 0 0 0 
Clinical research  0 0 0 0 
Conception  1 0 0 0 
Determine best way to generate useful cells  0 0 0 0 
Ethics  0 0 0 0 
Future use  0 0 0 0 
Hope to families  0 0 0 0 
Human lives  0 0 0 0 
Inheritance rights  1 0 0 0 
IVF   0 0 0 0 





0 Less expense  
Life saving  
1 
0 0 0 0 
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Post-Infertility Treatment Pentadic Sets: Adoption, Birth, Care for Embryo, Donation 
  








Purpose     
Limitations of adult stem cells  0 0 0 0 
Medical   0 0 0 1 
Name of adoptive family  1 0 0 0 
Not about abortion  1 0 0 0 
Not derivation of ES cell line  0 0 0 0 
Parenting a waiting child  1 0 0 0 
Possible medical benefits  0 0 0 0 
Preserve commercial value  0 0 0 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 
Research  0 0 0 3 
Science  0 0 0 0 
To give same rights as person  0 0 0 0 
Value embryos  0 0 0 0 
Welcome citizens of the country  1 0 0 0 
Scene         
Adoption   4 0 0 0 
After IVF   0 0 0 0 
Age  1 0 0 0 
Alternative to guidelines  0 0 0 0 
Animal  0 0 0 0 
Availability of hES cells  0 0 0 0 
Belief   1 0 0 0 
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Post-Infertility Treatment Pentadic Sets: Adoption, Birth, Care for Embryo, Donation 
  








Scene     
Children  2 0 0 0 
Closer scientific examination  0 0 0 0 
Commercial  0 0 0 0 
Complete IVF process  6 0 0 2 
Controversial subject in Washington  0 0 0 0 
Debate   1 0 0 0 
Described discovery of hES cell techniques  0 0 0 0 
Documents  1 0 0 0 
Embryo  0 0 0 2 
ESC qualities   0 0 0 0 
Ethical standards   0 0 0 0 
Ethics  0 0 0 1 
Excess   0 0 0 2 
Excitement  0 0 0 0 
Family  3 0 0 0 
Funding   1 0 0 0 
Future   0 0 0 0 
hES cells defined  0 0 0 1 
Home  2 0 0 0 
Hope   0 0 0 0 
Imagination  0 0 0 0 
Law   2 0 0 0 
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Post-Infertility Treatment Pentadic Sets: Adoption, Birth, Care for Embryo, Donation 
  








Scene     
Legislation   0 0 0 1 
Medicine   2 0 0 4 
Moral uncertainty  0 0 0 0 
Morality of situation   0 0 0 0 
Nation   3 1 0 1 
NBAC  0 0 0 1 
Not enough data on types of stem cells  0 0 0 0 
Not in excess of clinical need  1 0 0 0 
Number of fertilized eggs   0 0 0 1 
Only animal and transformed human cells available in past  0 0 0 0 
Outside womb or uterus  1 0 0 0 
Parts and Phases of embryo   0 0 0 0 
Place   1 0 0 2 
Pregnancy   3 0 0 0 
Qualities of ES cell lines  0 0 0 0 
Qualities of stem cells  0 0 0 0 
Quality of life  0 0 0 0 
Religion  1 0 0 0 
Scientist words   0 0 0 0 
Separation between acts  0 0 0 2 
Spirit of humanity   0 0 0 0 
Stages of embryo  0 0 0 1 
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Post-Infertility Treatment Pentadic Sets: Adoption, Birth, Care for Embryo, Donation 
  








Scene     
State of embryo  0 0 0 0 
State of hES cells  0 0 0 0 
Supporter of funding  0 0 0 0 
The past embryogenesis inaccessible  0 0 0 0 
Time   4 1 0 1 





Post-Infertility Treatment Pentadic Sets: Embryos Discarded, Embryos Frozen, Embryos Not Implanted, Legal Protection, No Chance 






















Agency             
Adoption  0 0 0 0 0 0 
Broader ban  0 0 0 1 0 0 
Cell lines  0 0 0 0 0 0 
Cells  0 0 0 0 0 0 
Characteristics of cells  0 0 0 0 0 0 
Differentiated cells  0 0 0 0 0 0 
Embryonic cells  1 0 0 0 0 0 
Embryonic tissues  0 0 0 0 0 0 
Embryos  2 0 0 0 0 0 
Ethical conduct  0 0 0 0 0 1 
FedEx  0 0 0 0 0 0 
Fertilized eggs  0 0 0 0 0 0 
Further inquiry  0 0 0 0 0 0 
Gene products  0 0 0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 0 0 
Growing cells  0 0 0 0 0 0 
Highest scientific standards 0 0 0 0 0 0 
Informed consent  0 0 0 0 0 2 
Inner cell mass cells  0 0 0 0 0 0 
IVF  2 1 0 0 1 0 
Lab technique  0 0 0 0 0 0 
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Post-Infertility Treatment Pentadic Sets: Embryos Discarded, Embryos Frozen, Embryos Not Implanted, Legal Protection, No Chance 






















Agency       
Legal conduct  0 0 0 0 0 0 
Licenses  0 0 0 0 0 0 
Overview and regulation  0 0 0 0 0 0 
Pregnancy  0 0 0 0 0 0 
Remains to be elucidated  0 0 0 0 0 0 
Stem cell development  0 0 0 0 0 0 
Stem cells  0 0 0 0 0 0 
Technology  0 0 0 0 1 0 
Thawing  0 0 0 0 0 0 
Transplantation of cells  0 0 0 0 0 0 
Transplantation of simple tissues  0 0 0 0 0 0 
Agent             
Any woman  0 0 0 0 0 0 
Congressman Smith  0 0 0 0 0 0 
Donors  0 0 0 0 0 0 
Embryos  0 0 0 0 0 0 
Family  0 4 0 0 0 0 
Federal government  0 0 0 2 0 0 
Human beings  0 0 0 0 0 0 
Industry  0 0 0 0 0 0 
IVF clinic  1 3 1 0 1 0 
Patent office  0 0 0 0 0 0 
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Agent       
Scientist 1 0 0 0 0 1 
Purpose             
Adoption agreement  0 0 0 0 0 0 
Adoption  0 0 0 0 0 0 
Adult stem cells  0 0 0 0 0 0 
Avoid embryo termination  0 1 1 0 0 0 
Basic research 0 0 0 0 0 0 
Benefit families 0 1 0 0 0 0 
Cell potential to supply unlimited cell quantities  0 0 0 0 0 0 
Cells are young 0 0 0 0 0 0 
Clinical research  0 0 0 0 0 0 
Conception  0 0 0 0 0 0 
Determine best way to generate useful cells  0 0 0 0 0 0 
Ethics  1 0 0 0 0 0 
Future use  0 1 0 0 0 0 
Hope to families  0 0 0 0 0 0 
Human lives  0 0 0 0 0 0 
Inheritance rights  0 0 0 0 0 0 
IVF   0 2 0 0 0 0 
Lab process  0 0 0 0 0 0 
Less expense  0 0 0 0 0 
0 
0 
0 Life saving  0 0 0 0 
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Purpose       
Limitations of adult stem cells  0 0 0 0 0 0 
Medical   2 1 0 0 0 0 
Name of adoptive family  0 0 0 0 0 0 
Not about abortion  0 0 0 0 0 0 
Not derivation of ES cell line  0 0 0 0 0 0 
Parenting a waiting child  0 0 0 0 0 0 
Possible medical benefits  0 0 0 0 0 0 
Preserve commercial value  0 0 0 0 0 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 0 0 
Research  2 0 0 0 0 2 
Science  0 0 0 0 0 0 
To give same rights as person  0 0 0 0 0 0 
Value embryos  1 0 0 0 0 0 
Welcome citizens of the country  0 0 0 0 0 0 
Scene             
Adoption   0 1 0 0 0 0 
After IVF   0 0 0 0 0 1 
Age  0 0 0 0 0 0 
Alternative to guidelines  0 0 0 0 0 0 
Animal  0 0 0 0 0 0 
Availability of hES cells  0 0 0 0 0 0 
Belief   0 0 0 0 0 0 
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Scene       
Children  0 1 0 0 0 0 
Closer scientific examination  0 0 0 0 0 0 
Commercial  0 0 0 0 0 0 
Complete IVF process  2 4 0 0 1 1 
Controversial subject in Washington  0 0 0 0 0 0 
Debate   0 1 0 0 0 0 
Described discovery of hES cell techniques  0 0 0 0 0 0 
Documents  0 0 0 0 0 0 
Embryo  0 0 0 0 0 0 
ESC qualities   0 0 0 0 0 0 
Ethical standards   0 0 0 0 0 0 
Ethics  1 0 0 0 1 0 
Excess   1 0 0 0 0 0 
Excitement  0 0 0 0 0 0 
Family  0 0 1 0 0 0 
Funding   0 0 0 0 0 0 
Future   0 0 0 0 0 0 
hES cells defined  0 0 1 0 0 0 
Home  0 0 0 0 0 0 
Hope   0 0 0 0 0 0 
Imagination  0 0 0 0 0 0 
Law   0 0 0 2 0 0 
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Scene       
Legislation   0 0 0 1 0 0 
Medicine   1 1 1 1 0 2 
Moral uncertainty  0 0 0 0 0 0 
Morality of situation   1 0 0 0 0 0 
Nation   0 0 0 0 0 0 
NBAC  0 0 0 0 0 0 
Not enough data on types of stem cells  0 0 0 0 0 0 
Not in excess of clinical need  0 0 0 0 0 0 
Number of fertilized eggs   0 0 0 0 0 0 
Only animal and transformed human cells 
available in past  0 0 0 0 0 0 
Outside womb or uterus  0 0 0 0 1 0 
Parts and Phases of embryo   0 0 0 0 0 0 
Place   0 0 1 0 0 0 
Pregnancy   0 0 2 1 0 0 
Qualities of ES cell lines  0 0 0 0 0 0 
Qualities of stem cells  0 0 0 0 0 0 
Quality of life  0 0 0 0 0 0 
Religion  1 0 0 0 0 0 









0 Separation between acts  
Spirit of humanity   
0 
0 0 0 0 0 0 
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Scene       
Stages of embryo  0 0 0 0 0 0 
State of embryo  0 0 0 0 0 0 
State of hES cells  0 0 0 0 0 0 
Supporter of funding  0 0 0 0 0 1 
The past embryogenesis inaccessible  0 0 0 0 0 0 
Time   0 3 0 1 0 1 



















Agency           
Adoption  0 0 0 0 0 
Broader ban  0 0 0 0 0 
Cell lines  0 0 0 0 0 
Cells  0 0 0 0 0 
Characteristics of cells  0 0 0 0 0 
Differentiated cells  0 0 0 0 0 
Embryonic cells  0 0 0 0 0 
Embryonic tissues  0 0 0 0 0 
Embryos  0 0 0 0 0 
Ethical conduct  0 0 0 0 0 
FedEx  0 0 0 0 0 
Fertilized eggs  0 0 0 0 0 
Further inquiry  0 0 0 0 0 
Gene products  0 0 0 0 0 
Genes that regulate development of 
stem cells  0 0 0 0 0 
Growing cells  0 0 0 0 0 
Highest scientific standards 0 0 0 0 0 
Informed consent  0 0 0 0 0 
Inner cell mass cells  0 0 0 0 0 
IVF  0 0 0 0 0 
Lab technique  0 0 0 0 0 
Legal conduct  0 0 0 0 0 
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Agency      
Licenses  0 0 0 0 0 
Overview and regulation  0 0 0 0 0 
Pregnancy  0 0 0 0 0 
Remains to be elucidated  0 0 0 0 0 
Stem cell development  0 0 0 0 0 
Stem cells  0 0 0 0 0 
Technology  0 0 0 0 0 
Thawing  0 0 0 0 0 
Transplantation of cells  0 0 0 0 0 
Transplantation of simple tissues  0 0 0 0 0 
Agent           
Any woman  0 0 0 0 0 
Congressman Smith  0 0 0 0 0 
Donors  0 0 0 0 0 
Embryos  0 0 0 0 0 
Family  0 1 0 1 1 
Federal government  0 0 0 0 0 
Human beings  0 0 0 0 0 
Industry  0 0 0 0 0 
IVF clinic  0 0 0 0 0 
Patent office  0 0 0 0 0 





  Purpose   
0 
  
0 Adoption agreement  0 0 0 
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Purpose      
Adoption  0 0 0 0 0 
Adult stem cells  0 0 0 0 0 
Avoid embryo termination  0 0 0 0 0 
Basic research 0 0 0 0 0 
Benefit families 0 0 0 0 0 
Cell potential to supply unlimited 
cell quantities  0 0 0 0 0 
Cells are young 0 0 0 0 0 
Clinical research  0 0 0 0 0 
Conception  0 0 0 0 0 
Determine best way to generate 
useful cells  0 0 0 0 0 
Ethics  0 0 0 0 0 
Future use  0 0 0 0 0 
Hope to families  0 0 0 0 0 
Human lives  0 0 0 0 0 
Inheritance rights  0 0 0 0 0 
IVF   0 0 0 0 0 
Lab process  0 0 0 0 0 
Less expense  0 0 0 0 0 
Life saving  0 0 0 0 
0 
0 
0 Limitations of adult stem cells  






0 0 0 
Name of adoptive family  0 0 0 0 0 
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Purpose      
Not about abortion  0 0 0 0 0 
Not derivation of ES cell line  0 0 0 0 0 
Parenting a waiting child  0 0 0 0 0 
Possible medical benefits  0 0 0 0 0 
Preserve commercial value  0 0 0 0 0 
Reduce reliance on human fetal 
and animal tissue  0 0 0 0 0 
Research  0 0 0 0 0 
Science  0 0 0 0 0 
To give same rights as person  0 0 0 0 0 
Value embryos  0 0 0 0 0 
Welcome citizens of the country  0 0 0 0 0 
Scene           
Adoption   1 0 0 0 0 
After IVF   0 0 0 0 0 
Age  0 0 0 0 0 
Alternative to guidelines  0 0 0 0 0 
Animal  0 0 0 0 0 
Availability of hES cells  0 0 0 0 0 
Belief   0 0 0 0 0 
Children  0 0 0 0 0 












Complete IVF process  0 0 0 0 0 
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Scene      
Controversial subject in 
Washington  0 0 0 0 0 
Debate   0 0 0 0 0 
Described discovery of hES cell 
techniques  0 0 0 0 0 
Documents  0 0 0 0 0 
Embryo  0 0 0 0 0 
ESC qualities   0 0 0 0 0 
Ethical standards   0 0 0 0 0 
Ethics  0 0 0 0 0 
Excess   0 0 0 0 0 
Excitement  0 0 0 0 0 
Family  0 0 0 0 0 
Funding   0 0 0 0 0 
Future   0 0 0 0 0 
hES cells defined  0 0 0 0 0 
Home  0 0 0 0 0 
Hope   0 0 0 0 0 
Imagination  0 0 0 0 0 
Law   0 0 0 0 1 
Legislation   0 0 0 0 0 
Medicine   











Morality of situation   0 0 0 0 0 
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Scene      
Nation   0 0 1 1 0 
NBAC  0 0 0 0 0 
Not enough data on types of stem 
cells  0 0 0 0 0 
Not in excess of clinical need  0 0 0 0 0 
Number of fertilized eggs   0 0 0 0 0 
Only animal and transformed 
human cells available in past  0 0 0 0 0 
Outside womb or uterus  0 0 0 0 0 
Parts and Phases of embryo   0 0 0 0 0 
Place   0 0 0 0 0 
Pregnancy   0 1 1 0 0 
Qualities of ES cell lines  0 0 0 0 0 
Qualities of stem cells  0 0 0 0 0 
Quality of life  0 0 0 0 0 
Religion  0 0 0 0 0 
Scientist words   0 0 0 0 0 
Separation between acts  0 0 0 0 0 
Spirit of humanity   0 0 0 0 0 
Stages of embryo  0 0 0 0 0 
State of embryo  0 0 0 0 0 
State of hES cells  0 0 0 0 0 
Supporter of funding  0 0 0 0 0 
0 The past embryogenesis inaccessible 0 0 0 0 
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Scene      
Time   0 1 0 0 0 





Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Agency       
Adoption  0 0 0 
Broader ban  0 0 0 
Cell lines  0 0 0 
Cells  0 0 0 
Characteristics of cells  0 0 0 
Differentiated cells  0 0 0 
Embryonic cells  0 0 0 
Embryonic tissues  0 0 0 
Embryos  0 0 0 
Ethical conduct  0 0 0 
FedEx  0 0 0 
Fertilized eggs  0 0 0 
Further inquiry  0 0 0 
Gene products  0 0 0 
Genes that regulate development of stem cells  0 0 0 
Growing cells  0 0 0 
Highest scientific standards 0 0 0 
Informed consent  0 0 0 
Inner cell mass cells  0 0 0 
IVF  0 0 0 
Lab technique  0 0 0 
Legal conduct  0 0 0 
Licenses  0 0 0 
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Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Agency    
Overview and regulation  0 0 0 
Pregnancy  0 0 0 
Remains to be elucidated  0 0 0 
Stem cell development  0 0 0 
Stem cells  0 0 0 
Technology  0 0 0 
Thawing  0 0 0 
Transplantation of cells  0 0 0 
Transplantation of simple tissues  0 0 0 
Agent       
Any woman  0 0 0 
Congressman Smith  0 0 0 
Donors  0 0 0 
Embryos  0 0 0 
Family  0 0 0 
Federal government  0 0 0 
Human beings  0 0 0 
Industry  0 0 0 
IVF clinic  0 0 0 
Patent office  0 0 0 
Scientist 0 0 0 
Purpose       
Adoption agreement  0 0 0 
Adoption  0 0 
0 
0 
0 Adult stem cells  0 
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Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Purpose    
Avoid embryo termination  0 0 0 
Basic research 0 0 0 
Benefit families 0 0 0 
Cell potential to supply unlimited cell quantities  0 0 0 
Cells are young 0 0 0 
Clinical research  0 0 0 
Conception  0 0 0 
Determine best way to generate useful cells  0 0 0 
Ethics  0 0 0 
Future use  0 0 0 
Hope to families  0 0 0 
Human lives  0 0 0 
Inheritance rights  0 0 0 
IVF   0 0 0 
Lab process  0 0 0 
Less expense  0 0 0 
Life saving  0 0 0 
Limitations of adult stem cells  0 0 0 
Medical   1 0 0 
Name of adoptive family  0 0 0 
Not about abortion  0 0 0 
Not derivation of ES cell line  0 0 0 
Parenting a waiting child  0 0 0 
Possible medical benefits  0 0 0 
Preserve commercial value  0 0 0 
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Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Purpose    
Reduce reliance on human fetal and animal tissue  0 0 0 
Research  0 0 0 
Science  0 0 0 
To give same rights as person  0 0 0 
Value embryos  0 0 0 
Welcome citizens of the country  0 0 0 
Scene       
Adoption   0 0 0 
After IVF   0 0 0 
Age  0 0 0 
Alternative to guidelines  0 0 0 
Animal  0 0 0 
Availability of hES cells  0 0 0 
Belief   0 0 0 
Children  0 0 0 
Closer scientific examination  0 0 0 
Commercial  0 0 0 
Complete IVF process  0 0 0 
Controversial subject in Washington  0 0 0 
Debate   0 0 0 
Described discovery of hES cells techniques  0 0 0 
Documents  0 0 0 
Embryo  0 0 0 
ESC qualities   0 0 0 
Ethical standards   0 0 0 
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Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Scene    
Ethics  0 0 0 
Excess   0 0 0 
Excitement  0 0 0 
Family  0 0 0 
Funding   0 0 0 
Future   0 0 0 
hES cells defined  0 0 0 
Home  0 0 0 
Hope   0 0 0 
Imagination  0 0 0 
Law   0 0 0 
Legislation   0 0 0 
Medicine   0 0 0 
Moral uncertainty  0 0 0 
Morality of situation   0 0 0 
Nation   0 0 0 
NBAC  0 0 0 
Not enough data on types of stem cells  0 0 0 
Not in excess of clinical need  0 0 0 
Number of fertilized eggs   0 0 0 
Only animal and transformed human cells available in past  0 0 0 
Outside womb or uterus  0 0 0 
Parts and Phases of embryo   0 0 0 
Place   0 1 1 
Pregnancy   0 0 0 
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Research Pentadic Sets: Bank Cell Lines, Cells Replated, Cells Dissociated  
Pentadic Elements Bank Cell Lines  Cells Replated Cells Dissociated  
Scene    
Qualities of ES cell lines  0 0 0 
Qualities of stem cells  0 0 0 
Quality of life  0 0 0 
Religion  0 0 0 
Scientist words   0 0 0 
Separation between acts  0 0 0 
Spirit of humanity   0 0 0 
Stages of embryo  0 0 0 
State of embryo  1 0 0 
State of hES cells  0 0 0 
Supporter of funding  0 0 0 
The past embryogenesis inaccessible  0 0 0 
Time   0 1 1 





Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Agency           
Adoption  0 0 0 0 0 
Broader ban  0 0 0 0 0 
Cell lines  0 0 0 0 2 
Cells  0 0 0 0 0 
Characteristics of cells  0 0 0 0 0 
Differentiated cells  0 0 0 0 0 
Embryonic cells  0 0 0 0 0 
Embryonic tissues  0 0 0 0 0 
Embryos  0 0 0 0 1 
Ethical conduct  0 0 0 0 0 
FedEx  0 0 0 0 0 
Fertilized eggs  0 0 0 0 0 
Further inquiry  0 0 0 0 0 
Gene products  0 0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 0 
Growing cells  0 0 0 0 0 
Highest scientific standards 0 0 0 0 0 
Informed consent  0 0 0 0 0 
Inner cell mass cells  0 0 1 0 0 
IVF  0 0 0 0 0 
Lab technique  0 0 0 0 4 
Legal conduct  0 0 0 0 0 
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Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Agency      
Licenses  0 0 0 0 0 
Overview and regulation  0 0 0 0 0 
Pregnancy  0 0 0 0 0 
Remains to be elucidated  0 0 0 0 0 
Stem cell development  0 0 0 0 0 
Stem cells  0 0 0 0 4 
Technology  0 0 0 0 0 
Thawing  0 0 0 0 0 
Transplantation of cells  0 0 0 0 0 
Transplantation of simple tissues  0 0 0 0 0 
Agent           
Any woman  0 0 0 0 0 
Congressman Smith  0 0 0 0 0 
Donors  0 0 0 0 0 
Embryos  0 0 0 0 0 
Family  0 0 0 0 0 
Federal government  0 0 0 0 0 
Human beings  0 0 0 0 0 
Industry  0 0 0 0 0 
IVF clinic  0 0 0 0 0 
Patent office  0 0 0 0 0 
Scientist 0 0 1 1 7 
           
153 
(Continued) Table A14 
Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Purpose      
Adoption agreement  0 0 0 0 0 
Adoption  0 0 0 0 0 
Adult stem cells  0 0 0 0 0 
Avoid embryo termination  0 0 0 0 0 
Basic research 0 0 0 0 0 
Benefit families 0 0 0 0 0 
Cell potential to supply unlimited cell quantities  0 0 0 0 1 
Cells are young 0 0 0 0 1 
Clinical research  0 0 0 0 0 
Conception  0 0 0 0 0 
Determine best way to generate useful cells  0 0 0 0 1 
Ethics  0 0 0 0 0 
Future use  0 0 0 0 0 
Hope to families  0 0 0 0 0 
Human lives  0 0 0 0 0 
Inheritance rights  0 0 0 0 0 
IVF   0 0 0 0 0 
Lab process  0 0 0 0 0 
Less expense  0 0 0 0 0 
Life saving  0 0 0 0 0 
Limitations of adult stem cells  0 0 0 0 0 
Medical   0 0 1 0 8 
Name of adoptive family  0 0 0 0 0 
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Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Purpose      
Not about abortion  0 0 0 0 0 
Not derivation of ES cell line  0 0 0 0 0 
Parenting a waiting child  0 0 0 0 0 
Possible medical benefits  0 0 0 0 0 
Preserve commercial value  0 0 0 0 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 0 
Research  0 0 0 2 6 
Science  0 0 0 0 0 
To give same rights as person  0 0 0 0 0 
Value embryos  0 0 0 0 0 
Welcome citizens of the country  0 0 0 0 0 
Scene           
Adoption   0 0 0 0 0 
After IVF   0 0 0 0 1 
Age  0 0 0 0 0 
Alternative to guidelines  0 0 0 0 0 
Animal  0 0 0 0 0 
Availability of hES cells  0 0 0 1 0 
Belief   0 0 0 0 0 
Children  0 0 0 0 0 
Closer scientific examination  0 0 0 0 0 
Commercial  0 0 0 0 0 
Complete IVF process  0 0 0 0 0 
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Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Scene      
Controversial subject in Washington  0 0 0 0 0 
Debate   0 0 0 0 0 
Described discovery of hES cell techniques  0 0 0 1 1 
Documents  0 0 0 0 0 
Embryo  0 0 1 0 6 
ESC qualities   0 0 0 0 0 
Ethical standards   0 0 0 0 0 
Ethics  0 0 1 0 1 
Excess   0 0 0 0 2 
Excitement  0 0 0 1 0 
Family  0 0 0 0 0 
Funding   0 0 0 0 3 
Future   0 0 0 0 0 
hES cells defined  0 0 0 0 1 
Home  0 0 0 0 0 
Hope   0 0 0 0 0 
Imagination  0 0 0 0 0 
Law   0 0 1 0 0 
Legislation   0 0 0 0 2 
Medicine   0 1 0 0 8 
Moral uncertainty  0 0 0 0 0 
Morality of situation   0 0 0 0 0 
Nation   0 0 0 0 1 
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Research Pentadic Sets: Cells Harvested, Cells Purified, Create New Source of Cells, Culture, Derivation 
Pentadic Elements Cells 
Harvested  
Cells Purified  Create New 
Source of Cells 
Culture  Derivation
  
Scene      
NBAC  0 0 0 0 1 
Not enough data on types of stem cells  0 0 0 0 0 
Not in excess of clinical need  0 0 0 0 0 
Number of fertilized eggs   0 0 0 0 0 
Only animal and transformed human cells available in past 0 0 0 0 0 
Outside womb or uterus  0 0 0 0 1 
Parts and Phases of embryo   0 0 0 0 1 
Place   0 0 0 2 6 
Pregnancy   0 0 0 0 0 
Qualities of ES cell lines  0 0 0 0 1 
Qualities of stem cells  0 0 0 1 0 
Quality of life  0 0 0 0 0 
Religion  0 0 0 0 0 
Scientist words   0 0 1 1 4 
Separation between acts  0 0 0 0 0 
Spirit of humanity   0 0 0 0 0 
Stages of embryo  0 0 1 1 3 
State of embryo  0 0 0 0 0 
State of hES cells  0 0 0 0 0 
Supporter of funding  0 0 0 0 0 
The past embryogenesis inaccessible  0 0 0 1 0 
Time   0 0 1 0 5 









Differentiation Discovery of 
hES cells  
Establish New 







Agency           
Adoption  0 0 0 0 0 
Broader ban  0 0 0 0 0 
Cell lines  0 0 0 0 0 
Cells  0 0 0 0 0 
Characteristics of cells  1 0 0 0 1 
Differentiated cells  0 0 0 0 0 
Embryonic cells  0 0 0 0 0 
Embryonic tissues  0 0 0 0 0 
Embryos  0 0 0 0 0 
Ethical conduct  0 0 0 0 0 
FedEx  0 0 0 0 0 
Fertilized eggs  0 0 0 0 0 
Further inquiry  0 0 0 0 0 
Gene products  0 0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 0 
Growing cells  0 1 0 0 0 
Highest scientific standards 0 0 0 0 0 
Informed consent  0 0 0 0 0 
Inner cell mass cells  0 0 0 0 0 
IVF  0 0 0 0 0 
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Differentiation Discovery of 
hES cells  
Establish New 







Agency      
Lab technique  1 0 0 0 1 
Legal conduct  0 0 0 0 0 
Licenses  0 0 0 0 0 
Overview and regulation  0 0 0 0 0 
Pregnancy  0 0 0 0 0 
Remains to be elucidated  1 0 0 0 0 
Stem cell development  0 0 0 0 0 
Stem cells  4 0 0 1 3 
Technology  0 0 0 0 0 
Thawing  0 0 0 0 0 
Transplantation of cells  0 0 0 0 0 
Transplantation of simple tissues  0 0 0 0 0 
Agent           
Any woman  0 0 0 0 0 
Congressman Smith  0 0 0 0 0 
Donors  0 0 0 0 0 
Embryos  0 0 0 0 0 
Family  0 0 0 0 0 
Federal government  0 0 0 0 0 
Human beings  0 0 0 0 0 
Industry  1 0 0 0 0 
IVF clinic  0 0 0 0 0 
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Differentiation Discovery of 
hES cells  
Establish New 







Agent      
Patent office  0 0 0 0 0 
Scientist 3 1 1 0 1 
Purpose           
Adoption agreement  0 0 0 0 0 
Adoption  0 0 0 0 0 
Adult stem cells  0 0 0 0 0 
Avoid embryo termination  0 0 0 0 0 
Basic research 0 0 0 0 0 
Benefit families 1 0 0 0 0 
Cell potential to supply unlimited cell quantities  3 0 1 0 0 
Cells are young 0 0 0 0 0 
Clinical research  0 0 0 0 0 
Conception  0 0 0 0 0 
Determine best way to generate useful cells  0 0 0 0 0 
Ethics  0 0 0 0 0 
Future use  0 0 0 0 0 
Hope to families  0 0 0 0 0 
Human lives  0 0 0 0 0 
Inheritance rights  0 0 0 0 0 
IVF   1 0 0 0 0 





0 Less expense  0 0 
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Research Pentadic Sets: Differentiation, Discovery of hES Cells, Establish New Cell Lines, Genetically Manipulate Cells, Grow Cells 
Pentadic Element 
 
Differentiation Discovery of 
hES cells  
Establish New 







Purpose      
Life saving  0 0 0 0 0 
Limitations of adult stem cells  0 0 0 0 0 
Medical   8 0 2 3 5 
Name of adoptive family  0 0 0 0 0 
Not about abortion  0 0 0 0 0 
Not derivation of ES cell line  0 0 0 0 0 
Parenting a waiting child  0 0 0 0 0 
Possible medical benefits  0 0 0 0 0 
Preserve commercial value  0 0 0 0 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 0 
Research  2 0 0 0 0 
Science  0 0 0 0 0 
To give same rights as person  0 0 0 0 0 
Value embryos  0 0 0 0 0 
Welcome citizens of the country  0 0 0 0 0 
Scene           
Adoption   0 0 0 0 0 
After IVF   0 0 0 0 0 
Age  0 0 0 0 0 
Alternative to guidelines  0 0 0 0 0 
Animal  0 0 0 0 0 
Availability of hES cells  1 0 0 0 0 
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Research Pentadic Sets: Differentiation, Discovery of hES Cells, Establish New Cell Lines, Genetically Manipulate Cells, Grow Cells 
Pentadic Element 
 
Differentiation Discovery of 
hES cells  
Establish New 







Scene      
Belief   1 0 0 0 0 
Children  0 0 0 0 0 
Closer scientific examination  0 0 1 0 0 
Commercial  0 0 0 0 0 
Complete IVF process  0 0 0 0 0 
Controversial subject in Washington  0 0 0 0 0 
Debate   0 0 0 0 0 
Described discovery of hES cell techniques  0 1 1 0 1 
Documents  0 0 0 0 0 
Embryo  1 0 0 0 0 
ESC qualities   0 0 0 0 0 
Ethical standards   0 0 0 0 0 
Ethics  0 0 1 0 0 
Excess   0 0 0 0 0 
Excitement  0 0 0 0 0 
Family  0 0 0 0 0 
Funding   0 0 0 0 0 
Future   3 0 0 0 0 
hES cells defined  2 0 0 0 1 
Home  0 0 0 0 0 
Hope   2 0 0 0 0 
Imagination  0 0 0 0 0 
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Research Pentadic Sets: Differentiation, Discovery of hES Cells, Establish New Cell Lines, Genetically Manipulate Cells, Grow Cells 
Pentadic Element 
 
Differentiation Discovery of 
hES cells  
Establish New 







Scene      
Law   0 0 1 0 0 
Legislation   0 0 0 0 0 
Medicine   3 0 0 2 1 
Moral uncertainty  0 0 0 0 0 
Morality of situation   0 0 0 0 0 
Nation   0 0 1 0 0 
NBAC  0 0 0 0 0 
Not enough data on types of stem cells  0 0 0 0 0 
Not in excess of clinical need  0 0 0 0 0 
Number of fertilized eggs   0 0 0 0 0 
Only animal and transformed human cells available in past  1 0 0 0 0 
Outside womb or uterus  0 0 0 0 0 
Parts and Phases of embryo   1 0 0 0 1 
Place   4 0 1 1 2 
Pregnancy   0 0 0 0 0 
Qualities of ES cell lines  0 0 0 0 0 
Qualities of stem cells  0 0 0 0 0 
Quality of life  0 0 0 0 0 
Religion  0 0 0 0 0 
Scientist words   1 0 0 0 1 
Separation between acts  0 0 0 0 0 
Spirit of humanity   0 0 0 0 0 
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Research Pentadic Sets: Differentiation, Discovery of hES Cells, Establish New Cell Lines, Genetically Manipulate Cells, Grow Cells 
Pentadic Element 
 
Differentiation Discovery of 
hES cells  
Establish New 







Scene      
Stages of embryo  1 0 0 0 0 
State of embryo  0 0 1 0 0 
State of hES cells  0 0 0 0 1 
Supporter of funding  1 0 0 0 0 
The past embryogenesis inaccessible  0 0 0 0 0 
Time   2 2 0 1 1 














Isolation  Obtain Cells from 







Agency             
Adoption  0 0 0 0 0 0 
Broader ban  0 0 0 0 0 0 
Cell lines  0 0 0 0 6 0 
Cells  0 0 0 0 3 0 
Characteristics of cells  0 0 0 0 0 0 
Differentiated cells  0 0 0 0 1 0 
Embryonic cells  0 0 0 0 2 0 
Embryonic tissues  0 0 0 0 1 0 
Embryos  0 0 0 0 11 0 
Ethical conduct  0 0 0 0 3 0 
FedEx  0 0 0 0 0 0 
Fertilized eggs  0 0 0 0 1 0 
Further inquiry  0 0 0 0 0 0 
Gene products  0 0 0 0 0 0 
Genes that regulate development of stem cells  0 0 0 0 1 0 
Growing cells  0 0 0 0 0 0 
Highest scientific standards 0 0 0 0 1 0 
Informed consent  0 0 0 0 0 0 
Inner cell mass cells  0 0 0 0 0 0 
IVF  0 0 0 0 1 0 
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Isolation  Obtain Cells from 







Agency       
Lab technique  1 1 0 0 0 0 
Legal conduct  0 0 0 0 1 0 
Licenses  0 0 0 0 1 0 
Overview and regulation  0 0 0 0 1 0 
Pregnancy  0 0 0 0 0 0 
Remains to be elucidated  0 0 0 0 0 0 
Stem cell development  0 0 0 0 1 0 
Stem cells  0 0 0 0 24 0 
Technology  0 0 0 0 1 0 
Thawing  0 0 0 0 0 0 
Transplantation of cells  0 0 0 0 0 0 
Transplantation of simple tissues  0 0 0 0 0 0 
Agent             
Any woman  0 0 0 0 0 0 
Congressman Smith  0 0 0 0 0 0 
Donors  0 0 0 0 0 0 
Embryos  0 0 0 0 0 0 
Family  0 0 0 0 0 0 
Federal government  0 0 0 0 1 0 
Human beings  0 0 0 0 0 0 
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Isolation  Obtain Cells from 







Agent       
IVF clinic  0 0 0 0 0 0 
Patent office  0 0 0 0 1 0 
Scientist 1 3 0 1 15 1 
Purpose             
Adoption agreement  0 0 0 0 0 0 
Adoption  0 0 0 0 0 0 
Adult stem cells  0 0 0 0 1 0 
Avoid embryo termination  0 0 0 0 0 0 
Basic research 0 0 0 0 3 0 
Benefit families 0 0 0 0 3 0 
Cell potential to supply unlimited cell quantities  0 0 0 0 2 0 
Cells are young 0 0 0 0 0 0 
Clinical research  0 0 0 0 1 0 
Conception  0 0 0 0 0 0 
Determine best way to generate useful cells  0 0 0 0 0 0 
Ethics  0 0 0 0 1 0 
Future use  0 0 0 0 0 0 
Hope to families  0 0 0 0 1 0 
Human lives  0 0 0 0 0 0 
Inheritance rights  0 0 0 0 0 
0 
0 
0 IVF   0 0 0 0 
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Purpose       
Lab process  0 0 0 0 2 0 
Less expense  0 0 0 0 0 0 
Life saving  0 0 0 0 0 0 
Limitations of adult stem cells  0 0 0 0 1 0 
Medical   1 3 0 0 25 0 
Name of adoptive family  0 0 0 0 0 0 
Not about abortion  0 0 0 0 0 0 
Not derivation of ES cell line  0 0 0 0 0 0 
Parenting a waiting child  0 0 0 0 0 0 
Possible medical benefits  0 0 0 0 0 0 
Preserve commercial value  0 0 0 0 2 0 
Reduce reliance on human fetal and animal tissue  0 0 0 0 0 0 
Research  0 2 0 0 13 0 
Science  0 0 0 0 0 0 
To give same rights as person  0 0 0 0 1 0 
Value embryos  0 0 0 0 1 0 
Welcome citizens of the country  0 0 0 0 0 0 
Scene             
Adoption   0 0 0 0 0 0 
After IVF   0 0 0 0 0 0 
Age  0 0 0 0 0 0 
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Scene       
Alternative to guidelines  0 0 0 0 1 0 
Animal  0 0 0 0 0 0 
Availability of hES cells  0 0 0 0 1 0 
Belief   0 0 0 0 6 0 
Children  0 0 0 0 0 0 
Closer scientific examination  0 0 0 0 0 0 
Commercial  0 0 0 0 3 0 
Complete IVF process  0 0 0 0 0 0 
Controversial subject in Washington  0 0 0 0 1 0 
Debate   0 0 0 0 3 0 
Described discovery of hES cell techniques  0 2 0 0 2 0 
Documents  0 0 0 0 3 0 
Embryo  0 1 0 0 1 0 
ESC qualities   0 0 0 0 0 0 
Ethical standards   0 0 0 0 4 0 
Ethics  0 0 0 0 13 0 
Excess   0 0 0 0 3 0 
Excitement  0 1 0 0 2 0 
Family  0 0 0 0 1 0 
Funding   0 1 0 0 13 0 
Future   0 0 0 0 1 0 
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Scene       
hES cells defined  0 1 0 0 3 0 
Home  0 0 0 0 0 0 
Hope   0 1 0 0 2 0 
Imagination  0 0 0 0 1 0 
Law   0 0 0 0 6 0 
Legislation   0 0 0 0 2 0 
Medicine   0 4 1 0 20 0 
Moral uncertainty  0 0 0 0 0 0 
Morality of situation   0 0 0 0 3 0 
Nation   0 0 0 0 6 0 
NBAC  0 0 0 0 3 0 
Not enough data on types of stem cells  0 0 0 0 1 0 
Not in excess of clinical need  0 0 0 0 0 0 
Number of fertilized eggs   0 0 0 0 1 0 
Only animal and transformed human cells available in past  0 0 0 0 0 0 
Outside womb or uterus  0 0 0 0 1 0 
Parts and Phases of embryo   0 0 0 0 0 0 
Place   3 4 1 1 18 1 
Pregnancy   0 0 0 0 0 0 
Qualities of ES cell lines  0 0 0 0 0 0 
Qualities of stem cells  0 0 0 0 0 0 
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Scene       
Quality of life  0 0 0 0 0 0 
Religion  0 0 0 0 1 0 
Scientist words   0 2 0 0 14 0 
Separation between acts  0 0 0 0 1 0 
Spirit of humanity   0 0 0 0 1 0 
Stages of embryo  0 2 0 0 2 0 
State of embryo  0 0 0 0 0 0 
State of hES cells  0 1 0 0 1 0 
Supporter of funding  0 0 0 0 10 0 
The past embryogenesis inaccessible  0 0 0 0 1 0 
Time   1 1 0 0 13 0 





Treatment Pentadic Set 
 
Pentadic Element Treatment 
Agency   
Adoption  0 
Broader ban  0 
Cell lines  2 
Cells  0 
Characteristics of cells  1 
Differentiated cells  2 
Embryonic cells  1 
Embryonic tissues  0 
Embryos  0 
Ethical conduct  0 
FedEx  0 
Fertilized eggs  0 
Further inquiry  1 
Gene products  1 
Genes that regulate development of stem cells  0 
Growing cells  0 
Highest scientific standards 0 
Informed consent  0 
Inner cell mass cells  0 
IVF  1 
Lab technique  0 
Legal conduct  0 
Licenses  0 
Overview and regulation  0 
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Treatment Pentadic Set 
 
Pentadic Element Treatment 
Agency  
Pregnancy  0 
Remains to be elucidated  0 
Stem cell development  0 
Stem cells  11 
Technology  3 
Thawing  0 
Transplantation of cells  2 
Transplantation of simple tissues  1 
Agent   
Any woman  0 
Congressman Smith  0 
Donors  0 
Embryos  0 
Family  0 
Federal government  0 
Human beings  0 
Industry  1 
IVF clinic  0 
Patent office  0 
Scientist 2 
Purpose   
Adoption agreement  0 
Adoption  0 
Adult stem cells  0 
Avoid embryo termination  0 
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Treatment Pentadic Set 
 
Pentadic Element Treatment 
Purpose  
Basic research 0 
Benefit families 0 
Cell potential to supply unlimited cell quantities  1 
Cells are young 0 
Clinical research  0 
Conception  0 
Determine best way to generate useful cells  0 
Ethics  0 
Future use  0 
Hope to families  0 
Human lives  0 
Inheritance rights  0 
IVF   0 
Lab process  1 
Less expense  0 
Life saving  0 
Limitations of adult stem cells  0 
Medical   17 
Name of adoptive family  0 
Not about abortion  0 
Not derivation of ES cell line  0 
Parenting a waiting child  0 
Possible medical benefits  0 
Preserve commercial value  0 
Reduce reliance on human fetal and animal tissue  1 
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Treatment Pentadic Set 
 
Pentadic Element Treatment 
Purpose  
Research  1 
Science  0 
To give same rights as person  0 
Value embryos  0 
Welcome citizens of the country  0 
Scene   
Adoption   0 
After IVF   0 
Age  1 
Alternative to guidelines  0 
Animal  3 
Availability of hES cells  1 
Belief   2 
Children  0 
Closer scientific examination  0 
Commercial  2 
Complete IVF process  0 
Controversial subject in Washington  0 
Debate   0 
Described discovery of hES cell techniques  1 
Documents  2 
Embryo  0 
ESC qualities   1 
Ethical standards   0 
Ethics  1 
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Treatment Pentadic Set 
 
Pentadic Element Treatment 
Scene  
Excess   0 
Excitement  1 
Family  0 
Funding   1 
Future   3 
hES cells defined  1 
Home  0 
Hope   1 
Imagination  0 
Law   0 
Legislation   0 
Medicine   9 
Moral uncertainty  0 
Morality of situation   1 
Nation   1 
NBAC  0 
Not enough data on types of stem cells  0 
Not in excess of clinical need  0 
Number of fertilized eggs   0 
Only animal and transformed human cells available in past  0 
Outside womb or uterus  0 
Parts and Phases of embryo   0 
Place   6 
Pregnancy   0 
Qualities of ES cell lines  0 
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Treatment Pentadic Set 
 
Pentadic Element Treatment 
Scene  
Qualities of stem cells  1 
Quality of life  1 
Religion  0 
Scientist words   3 
Separation between acts  0 
Spirit of humanity   0 
Stages of embryo  1 
State of embryo  0 
State of hES cells  0 
Supporter of funding  2 
The past embryogenesis inaccessible  1 
Time   5 
        Types of cells 1 
 
 
